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ABSTRACT 
 
Bacteroides fragilis is an opportunistic pathogen which can cause life threatening infections in 
humans and animals. The increasing incidence of antibiotic resistance by the bacterium has 
prompted the search for novel therapeutic targets. The idea of antivirulence over antimicrobial 
drug development is becoming increasingly popular and invites detailed research into the 
virulence factors of target pathogens. The ability to adhere to, and degrade components of the 
extracellular matrix, such as collagen, is critical in bacterial colonisation and host cell invasion.  
The aim of this dissertation was to specifically identify the collagen type I adhesins and 
proteases in the common research strain, B. fragilis 638R, as well as in 23 clinical isolates from 
Groote Schuur Hospital (GSH), Cape Town.  
 
Initial zymography studies in B. fragilis 638R, using co-polymerised collagen SDS-PAGE, 
showed that the bacterium produced two collagenases (~45 and ~37 kDa). A candidate gene for 
the predominant ~45 kDa protease was identified in the published B. fragilis 638R genome 
annotation using bioinformatic analysis, and a gene specific mutation created in order to confirm 
function. The 45 kDa collagen protease was, however, still present in the mutant indicating that 
the candidate gene did not encode the observed enzyme. Particle agglutination assays (PAA) 
were used to compare the collagen binding ability of B. fragilis 638R and 23 clinical isolates.    
B. fragilis 638R. Five of the clinical strains were found to bind collagen more strongly then B. 
fragilis 638R. These were also analysed by zymography and collagen Far Western (FW) 
detection and found to have identical collagen adhesin and protein profiles.  One of these 5 good 
collagen adherent clinical isolates, GSH18, was therefore chosen for further analysis. The two 
collagenases (~37 and 45 kDa) were found to be present in both the outer-membrane (OMP) and 
cell free extracts (CFE) fractions. A collagen adhesin was detected in the CFE at ~45 kDa, and 
an adhesin doublet of ~34 and ~33 kDa was observed in the OMP fraction.  
 
Two-dimensional SDS-PAGE was employed to identify all collagen adhesins present in the 
OMP fraction, and collagen affinity chromatography was used to purify putative collagen 
adhesins in both the OMP and CFE fractions.  Mass spectroscopy was then used for 
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identification of the proteins of interest. The 34 kDa adhesin was found to be identical to the 
hypothetical protein encoded by the ORF BF0586 of B. fragilis 9343, named here cbp (collagen 
binding protein). Functionality of the protein was confirmed in B. fragilis GSH18 by targeted 
insertional mutagenesis of the cbp gene and demonstrating the loss of the 34 kDa adhesin protein 
band. Heterologous expression of the Cbp protein in Escherichia coli followed by collagen Far 
Western analysis, confirmed that Cpb was able to adhere to collagen. This study is the first to 
report the presence of collagen type I proteases and adhesins in B. fragilis and to assign function 
to a specific gene encoding a collagen binding protein. 
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ABBREVIATIONS 
 
°C     degree(s) Celsius 
aa     amino acid(s) 
A     adenosine 
Amp     ampicillin 
bp     base pair(s) 
BSA     bovine serum albumin 
C     cytosine 
C-     carboxy-(terminal) 
CFE     cell free extract 
d-     distilled 
DNA     deoxyribonucleic acid 
dNTP     deoxynucleotide triphosphate 
DTT     dithiothreitol 
EDTA     ethylenediaminetetra acetic acid 
et al.      et alia 
g     acceleration due to gravity 
g     gram(s) 
G     guanine 
G+C     guanine and cytosine 
h     hour(s) 
IPTG     isopropyl β-D-1-thiogalactopyranoside 
Kan     kanamycin 
kb     kilobase pairs 
kDa     kilodalton(s) 
kV     kilovolt(s) 
LB     Luria-Bertani medium 
LC MS/MS    liquid chromatography tandem mass spectrometry 
M     molar 
MCS     multiple cloning site 
mg     milligram 
MIC     minimum inhibitory concentration 
min     minute(s)  
ml     millilitre(s) 
mM     millimolar 
MS/MS    tandem mass spectrometry 
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MTZ     metronidazole 
MW     molecular weight 
N-     amino-(terminal) 
n     number of samples 
NCBI     National Centre for Biotechnology Information 
nm     nanometre(s) 
nM     nanomolar 
ODx     optical density at x nanometres 
ORF     open reading frame 
ori     origin of replication 
P     p-value; indicating probability  
p     plasmid  
PAGE     polyacrylamide gel electrophoresis 
PCR     polymerase chain reaction 
RNA     ribonucleic acid 
rRNA     ribosomal RNA 
rpm     revolutions per minute 
RT     room temperature 
s     second(s) 
SDS     sodium dodecyl sulphate 
spp.     species 
T     thymine 
TAE     Tris-acetate-EDTA electrophoresis buffer   
TCA     trichloroacetic acid 
TMB     3,3‟,5,5‟-tetramethylbenzidine 
U     units 
UV     ultraviolet 
w/v     weight per volume 
WT     wild-type 
xR     resistance to x 
xS     sensitive to x  
α     alpha 
λ     lambda 
µg     microgram(s) 
µl     microlitre(s) 
µM     micromolar 
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1.1 INTRODUCTION TO BACTEROIDES FRAGILIS  
 
Bacteroides fragilis is an anaerobic, Gram negative, rod-shaped bacterium.  It is a normal 
inhabitant of the human colon where it has a commensal relationship with its host. In this 
capacity it is involved in assisting in digestion and in the maturation and development of the host 
immune system (Mazmanian et al., 2005; Mazmanian and Kasper, 2006).  However, under 
certain circumstances, some strains can become opportunistic pathogens. These are known to be 
able to cause abscess formation, soft-tissue infections, and bacteraemias (Pumbwe et al., 2006).  
B. fragilis is an organism of great interest due to its involvement in these life-threatening 
infections, and particularly due to the increased emergence of resistance to several of the 
antibiotics used in treatment in the clinical setting (Snydman et al., 2010).  
 
1.1.1 PHYLOGENY OF BACTEROIDES  
 
Members of the genus Bacteroides were originally defined obligately anaerobic gram-negative, 
nonmotile, non-sporeforming, pleomorphic rods with the guanine-cytosine (G+C) content of the 
group was ranging widely between 39 and 49% (Shah et al., 2009). The original characterisation 
of this group, based predominantly on morphological characteristics, grouped together organisms 
that varied substantially based on their physiological and biochemical characteristics. 
Clarification of the phylogeny of the genus has come a long way since the advent of technologies 
such as DNA-DNA hybridization and 16S rRNA gene sequence comparison. The outcome of 
these analyses resulted in the Bacteroides genus being deemed equivalent to the Bacteroides 
cluster of the Bacteroides sub-group in what is now know as the “Bacteriodetes” phylum, 
previously the cytophaga-flavobacter-bacteroides phylum (Shah et al., 2009). The species that 
conform to this Bacteroides genus include the ten members of the informal taxonomic group, “B. 
fragilis group” (Shah et al., 1989), including B. fragilis, as well as a number of other species. 
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1.1.2 METABOLIC PROPERTIES OF BACTEROIDES FRAGILIS 
 
 
1.1.2.1   CARBOHYDRATE METABOLISM 
 
B. fragilis is able to degrade both simple and complex oligosaccharides. In the human intestine, it 
uses undigested dietary sugars as well as host glycoproteins, such as mucin, as carbon sources. 
Host cell surface glycoproteins and glycolipids contain mannose, galactose and N-acetyl-D-
glucosamine (NAG) and other groups which can serve as carbon sources at the sites of infection 
(Baughn and Malamy, 2002; Brigham and Malamy, 2005).   
 
B. fragilis is not known to produce heme and so it was originally believed that an exogenous 
source of heme was an important growth requirement since  heme is an essential component of 
the cytochrome and is thus necessary for the function of the cytochrome b-dependent electron 
transport system which is responsible for the generation of ATP from glucose. It has, however, 
since been discovered that B. fragilis has both a heme-dependent and heme-independent pathway 
for α-ketoglutarate biosynthesis, which utilises enzymes of the reductive and oxidative branch of 
the Krebs cycle, respectively (Baughn and Malamy, 2002). 
 
There are other instances where carbon source as well environmental conditions, including 
oxidative stress, have been found to influence the carbon metabolism in B. fragilis. For example, 
Spence et al. (2006) described a starch utilisation operon, consisting of four genes, which was 
induced by starch, maltose and maltoologosaccharides, as well as by the presence of oxygen. It 
was, therefore, named the osu (oxygen-induced starch utilisation operon) (Spence et al., 2006).  
 
 
1.1.2.2   NITROGEN METABOLISM 
 
Nitrogen assimilation in bacteria is done mainly by the incorporation of ammonia into glutamate 
and glutamine, which are the principal nitrogen donors of most cells. There are two basic 
pathways for this incorporation: the glutamine synthetase/glutamate synthase (GS/GOGAT) 
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pathway and the glutamate dehydrogenase (GDH) pathway. These have been extensively studied 
in Escherichia coli (Merrick and Edwards, 1995). The routeof choice for the assimilation of 
nitrogen is dependent on the nitrogen source available. Under conditions of high ammonia (NH3) 
concentration, in E. coli, GDH is more active. During nitrogen limitation (usually under low 
ammonia conditions) the GS/GOGAT pathway is the more active one. In this case two sequential 
reactions take place. The first is the conversion of glutamate and ammonia into glutamine by 
glutamine synthetase type I (GSI) and the second is the transfer of the amide group from the 
glutamine to α-ketoglutarate by glutamate synthase (GOGAT) (Merrick and Edwards, 1995). 
 
Nitrogen metabolism in B. fragilis has certain novel features compared to E. coli. In contrast to 
E. coli, the glutamate dehydrogenase of B. fragilis serves as the main enzyme for the 
incorporation of ammonia under high and low ammonia conditions (Abrahams and Abratt, 
1998). Moreover, this bacterium has not one but two distinct GDH enzymes for this purpose. 
These are GdhA (gdhA), an NAD(P)H-dependent GDH, and GdhB (gdhB), which is NADH-
dependent (Abrahams and Abratt 1998, Abrahams 2002). These are regulated in different ways 
according to the nitrogen source. Another difference between the two bacteria is that, unlike the 
E. coli which has a type I glutamine synthetase, B. fragilis has a type III glutamate synthetase 
(Southern et al., 1986; van Rooyen et al., 2006). This type of GS was first discovered in this 
bacterium and is the only GS described for B. fragilis.  
 
In addition to ammonia, the human large intestine contains a large amount of proteinaceous 
substances found as a mixture of endogenous and dietary proteins and peptides (Macfarlane et 
al., 1988). These are metabolized by the intestinal microbiota via hydrolysis by proteases and 
peptidases. The resulting products are smaller peptides, amino acids, gases, and toxic substances 
like ammonia, phenols and indoles. B. fragilis has been shown to produce a number of proteases. 
In one study three proteases, termed P1, P 2 and P3, were found to be cell surface associated 
(Gibson and Macfarlane, 1988a). P 2 is a 52 kDa metalloprotease and P3 is a 34 kDa cystein 
protease. Both proteins appear to be endopeptidades associated with the cell surface whose 
function may be the initiation of proteolysis at this location. P1 is likely to be a 73 kDa serine 
exopeptidase protease with a strong ability to hydrolyse dipeptide substrates. P1 is located in the 
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periplasm and cytoplasm, its function possibly being further breakdown of peptides made by 
outer membrane proteases. 
 
Although the exact role of protease activity in the nutrition of B. fragilis is uncertain, it is clear 
that it is a significant one. This is seen, for example, by the fact that proteolytic activity can 
support growth on casein as the sole nitrogen source (Gibson and Macfarlane, 1988b). Protease 
activity in B. fragilis had been suggested to be a possible factor in the pathogenicity of the 
bacterium. This involvement of proteases in virulence is reviewed in greater detail later in this 
Chapter.  
 
 
1.1.3 ANTIBIOTIC RESISTANCE 
 
The antibiotics used for the treatment of B. fragilis infections include carbapenems (e.g. 
imipenem), piperacillin or piperacillin/tazobactam, moxifloxacin, cefoxitin, clindamycin (CLIN), 
chloramphenicol, metronidazole (MTZ) and recently tigecycline (TIG) (Hawser et al., 2010; 
Snydman et al., 2010). Worldwide surveys show the development of resistance to many of these 
antimicrobial agents. Susceptibility to carbapenems, piperacillin/tazobactam, moxifloxacin, 
CLIN, MTZ and TIG was tested on strains from various European countries, collected during the 
period of 2007 to 2008 (Hawser et al., 2010). The agents were active against more than 87 % of 
isolates except for CLIN which showed up to 22.6 % resistance. MTZ and TIG were the only 
drugs to which more than 90 % susceptibility was observed. Similarly, an American survey 
showed an increase in resistance to clindamycin of about 6 % in the 1980‟s to over 35 % in the 
current decade (Snydman et al., 2010). Most other agents remained highly effective with no 
resistance being observed for chloramphenicol, and only 2 isolates of B. fragilis displaying 
resistance to MTZ.  
 
Metronidazole remains the best antibiotic for the treatment of B. fragilis infections in the Hong 
Kong and Korea with no incidence of resistance reported between 1997 and 2007 (Chan et al., 
2010; Roh et al., 2009). In Korea the resistance to CLIN was shown to be extremely high (51 %), 
while sensitivity to chloramphenicol remained 100 % (Roh et al., 2009).  
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Very few antibiotic susceptibility surveys have been done of Bacteroides spp. in South Africa. 
The most recent study on antibiotic susceptibility of anaerobic isolates, showed that about 39 % 
of Bacteroides spp. tested were resistant to CLIN which is in line with the other studies 
discussed above (Meyer et al., 2006). The resistance to MTZ on the other hand was staggering. 
Of the invasive strains of Bacteroides tested, 22 % showed MTZR. This is a great contrast from 
studies done in Cape Town (Koch et al., 1998) and Johannesburg (Van de Westhuyzen and 
Chalkey, 1992) in the 1990s, which found no resistance to MTZ.  
 
This combined information shows that the threat of the antibiotic resistance is real and wide 
spread, and highlights the need for a search for alternative treatment solutions. Virulence factors 
are thought to have good potential as targets for novel vaccines and antimicrobial agents 
(Barczak and Hung, 2009; Stubben et al., 2009). The theory of antivirulence, instead of 
antimicrobial compound development is thought to have certain advantages (Barczak and Hung, 
2009). It is hypothesised that, because the target is not essential for survival in the host, there 
should be less, or no, selection for mutations that lead to resistance. Furthermore, since virulence 
factors are often very specific to an organism, and their targeting drugs are not likely to be lethal 
to other bacteria, there should be minimal impact on the rest of the host microbiota, therefore  
preventing secondary infection by drug-resistant bacteria.  
 
It is, therefore, of interest to review what is known about B. fragilis pathogenesis and virulence 
factors with a view to identifying potential therapeutic targets for treating infections.  
  
 
1.1.4 PATHOGENICITY AND VIRULENCE FACTORS  
 
Although B. fragilis plays a significant role as a commensal, it has the ability to become a 
significant opportunistic pathogen. It makes up only about 0.5% of the total intestinal microflora, 
yet it is the predominant isolate from clinical infections (Kalka-Moll et al., 2001). B. fragilis has 
been isolated from a number of anatomical sites in the human body inc luding the abdominal 
cavity, liver, brain, pelvis, lungs and the bloodstream (Pumbwe et al., 2006). Infection takes 
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place by the entry of the gut flora into damaged areas in the intestinal wall. Damage usually 
occurs due to gastrointestinal surgery, perforated appendicitis or ulcer, or gut trauma (Brook, 
2002). Colonisation of the previously sterile site is done by different bacteria, with aerobic 
bacteria being most active during the early stages of infection. The aerobes damage tissue and 
also reduce the oxidation-reduction potential of the colonised site allowing for the subsequent 
proliferation of the anaerobes (Pumbwe et al., 2006). Certain strains of B. fragilis have also been 
shown to cause gut disease, in the form of diarrhoea, in farm animals and humans (Moncrief et 
al., 1998).  
 
A number of virulence factors thought to be responsible for these infections have been identified. 
These include capsular polysaccharides, lipopolysaccharides (LPS), neuraminidases (sialidases), 
haemolysins and enterotoxins (B. fragilis toxin; BFT). These are reviewed below.   
 
 
1.1.4.1  CAPSULAR POLYSACCHARIDES 
 
B. fragilis forms a distinctive polysaccharide (PS) capsule which has been extensively studied 
(Patrick, 2002; Pumbwe et al., 2006). It has been linked to abscess formation and has also been 
shown to confer resistance to phagocytosis and killing (Coyne et al., 2000; Reid and Patrick, 
1984; Tzianabos et al., 1993).  
 
Three types of capsule have been observed, namely the micro-capsule (MC), the small capsule 
(SC) and the large capsule (LC). Each has different virulence characteristics and is believed to be  
produced by the expression of different PS loci (Patrick et al., 2009). Variable expression of 
polysaccharides forming the MC has been implicated as a virulence determinant. Ten annotated 
regions of the genome sequence of B. fragilis NCTC9343 have been implicated in the production 
of extracellular polysaccharides (PS A – J) (Patrick et al., 2009). Of these eight are related to 
variable MC expression (PS A – H). Recently these loci have also been identified in the B. 
fragilis strains YCH46 and 638R (Patrick et al., 2010). A very interesting mechanism of site-
specific inversion of promoter sequences occurs, causing seven of these loci to be switched 
“ON” or “OFF”, resulting in within-strain phase and antigenic variation (Coyne et al., 2003; 
12 
 
Patrick et al., 2003). Similarly, formation of the LC involves the variable expression of three  
genes, a putative initiating glycosyltransferase WbaP homologue, a putative Wza polysaccharide 
export/assembly protein homologue and a putative polysaccharide co-polymerase Wzs 
homologue (Patrick et al., 2010). Further levels of regulation of the expression of PS synthetic 
genes have been attributed to the presence of two genes, upxY and upxZ, found at the beginning 
of each PS locus, where x will be one of a-h depending on the locus they precede (Chatzidaki-
Livanis et al., 2010). The UpxY products are NusGSP transcriptional antiterminator factors and 
the UpxZ products are unique proteins without any known orthologues. The UpxZ proteins were 
shown to interact with UpxY proteins to prevent anti-termination therefore indirectly inhibiting 
the transcription of the PS loci (Chatzidaki-Livanis et al., 2010).  
 
Injection of capsule alone, or even purified PS A and B, into animal models caused the formation 
of abscesses, confirming its involvement in this process (Coyne et al., 2000). The large capsule 
conferred resistance to phagocytosis and killing whereas populations displaying predominantly 
the microcapsule were eliminated (Reid and Patrick, 1984). Despite these differences, the 
predominant feature of the polysaccharides remains the presence of a zwitterionic motif, shown 
to be necessary for their activities (Tzianabos et al., 1993). Interestingly, the zwitterionic 
polysaccharide is also important in the ability of B. fragilis to function as a commensal, as it has 
been shown to direct the maturation of the developing host immune system (Mazmanian et al., 
2005). PS A has been shown to modulate the expression of anti- inflamatory cytokines IL-10 and 
TGF-β2 by host Foxp3+ regulatory Tcells (Tregs), resulting in decreased inflammatory response 
in a mice models of intestinal inflammatory colitis (Round and Mazmanian, 2010). These 
conflicting consequences of the effects of the capsular polysaccharide of B. fragilis in the host 
illustrate this bacterium‟s dual role as a gut commensal and opportunistic pathogen.  
 
 
1.1.4.2  LIPOPOLYSACCHARIDES (LPS) 
 
These molecules are part of the cell wall of gram negative bacteria. When LPS comes into 
contact with host cells, it induces a strong immune response which can be toxic to the host cell. 
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Toll- like receptors (TLRs) recognise LPS and initiate the response of the innate immune system 
by stimulating signal transduction pathways via adaptor molecules (Mancuso et al., 2005).  
 
The exact nature B. fragilis LPS molecule is still controversial, as it does not conform to the 
classic enteric LPS paradigm (Patrick, 2002). Various biochemical differences have been noted, 
with the major issue revolving around the presence or absence of an enteric O-antigen- like 
polysaccharide (Patrick, 2002). Initially the B. fragilis LPS was found to use TLR4 to induce cell 
activation, in the presence of MD2 protein and CD14, which meant that B. fragilis LPS used the 
same receptors and co-receptors as other enterobacterial LPSs (Mancuso et al., 2005). However, 
it has recently been reported that the LPS, whether purified or in crude extract or killed whole 
cells, interactes with TLR2 and not TLR4 (Alhawi et al., 2009). 
 
 
1.1.4.3  NEURAMINIDASES 
 
Neuraminidases, otherwise known as sialidases, are enzymes that cleave the N-acetyl neuraminic 
acid (NANA [sialic acid]) residues of complex sugars and sugar containing molecules. It is 
believed that bacterial neuraminidases may be virulence factors in some pathogenic bacteria 
(Godoy et al., 1993).  Neuraminidases have been found in many B. fragilis strains, where a nanH 
gene encodes a neuraminidase with two possible functions for these for these enzymes have been 
suggested (Godoy et al., 1993; Pumbwe et al., 2006). The first is that neuraminidase activity may 
be important for cell growth and multiplication, and the second is that it may be involved in 
adhesion to host cells. The removal of sialic acid by neuraminidases is thought to expose 
adhesion sites to which lectin- like adhesins can bind (Domingues et al., 1992). Further 
information on the adhesin properties of B. fragilis is discussed later. 
 
 
1.1.4.4  HEMOLYSINS 
 
Most B. fragilis clinical isolates have been classified as non-hemolytic. However, it has been 
shown that this bacterium has 10 putative hemolysin genes (Robertson et al., 2006). Hemolysins 
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are cytotoxic enzymes that damage cell membranes leading to cell lysis.  The mechanisms by 
which hemolysins act include surfactant, pore formation and enzymatic action. Hemolysins 
HlyA, HlyB and HlyIII of B. fragilis have been shown to confer hemolytic activity to a non-
hemolytic E. coli strain and, HlyA and HlyB were shown to work together to enhance each 
others activity against erythrocytes (Robertson et al., 2006).  
 
 
1.1.4.5  B. FRAGILIS TOXIN (BFT) 
 
Toxigenic strains of B. fragilis, termed enterotoxigenic B. fragilis (ETBF), produce a 20 kDa 
extracellular secretory toxin called B. fragilis toxin (BFT) or fragilysin (Sears, 2001). This 
protein is not found in nontoxigenic B. fragilis strains (NTBF). ETBF strains have been found in 
association with diarrhea in children particularly under the age of 10 (Caceres et al., 2000). The 
first study in adults showed ETBF in approximately 27% of diarrhea patients and in 12% of 
healthy adult controls (Zhang et al., 1999). 
 
The BFT protein is produced as a holotoxin with a calculated molecular weight of about 44.5 
kDa. The predicted structure of this holotoxin consists of a signal peptide, important for targeting 
the holotoxin to the bacterial membrane, and a proprotein toxin domain (Sears, 2009). This 
second domain is thought to be important for correct protein folding and the export of the 
mature, active toxin of about 20 kDa. The mature toxin has been shown to be a zinc 
metalloprotease (Moncrief et al., 1995). 
 
Three BFT encoding genes, termed bft-1, bft-2 and Korea-bft or bft-3, have been discovered 
(Sears, 2009). Although all these genes are unique, they show great nucleotide homology. Each 
bft gene is found within as pathogenicity island (Buckwold et al., 2007). A pathogenicity island 
being defined as a region of DNA that has a G+C content that is different to that of the rest of the 
organism‟s chromosome and that contains more that one putative virulence gene.  The B. fragilis 
pathogenicity island (BfPAI) has been found to be integrated within a putative conjugative 
transposon (CTn) termed CTn86 (discovered in the ETBF strain 86-5443-2-2) (Buckwold et al., 
2007). This genetic element has been shown to be able to transfer between B. fragilis strains, i.e. 
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ETBF to NTBF, but so far no evidence of interorganism transfer has been seen (Sears et al., 
2009). It has, however, been hypothesized the BfPAI may have been acquired by ETBF strains 
from other organisms by the by means of conjugative transposition (Franco et al., 2004).  
 
Based on the information available, a model of the mechanism of action of BFT and how ETBF 
strains cause intestinal secretion was postulated (Figure. 1.1) (Sears 2009). The model describes 
by Sears (2009) proposes that the first step in the process involves the ETBF strain attachment to 
the apical membrane of intestinal epithelial cells followed by the secretion of BFT. The toxin 
then binds to the colonic epithelium cell (CEC) receptor therefore initiation a complex cascade of 
signal transduction events leading to the the activation of various inflammatory response 
molecules, including IL-8 and TGF-β, and to the rapid cleavage of tight junction protein, E-
cadherin. This cleavage is a two-step process by which the BFT releases the ectodomain of the 
E-cadherin and then the intracellular domain is processed by the host cell presenilin-1/γ-
secretase. Cleavage of the intracellular domain, resulting in changes in cell morphology and 
membrane function and correlates with the onset of colonic inflammation in an in vivo murine 
model (Rhee et al., 2009). 
 
An initial report by Toprak et al. (2006) showed an association between the colonization by 
ETBF strains and colorectal carcinoma. The putative carcinogenic potential of BFT has been 
supported by a number of findings. Figure 1.1 shows how the cleavage of E-cadherin induces the 
nuclear localization of β-catenin causing the upregulation in the transcription and translation of a 
β-catenin-regulated oncogene (c-myc) (Sears, 2009). BFT has also been shown to induce cellular 
proliferation in HT29/C1cells and to make these higly mobile, a phenomenon consistant with 
observations that a decrease in E-cadherin in tumour cells increases their metastatic potential 
(Sears, 2009). Finally, BFT also induces p38 mitogen-activated protein kinase (p38 MAPK) and 
cyclooxygenase-2 (COX-2) signaling which in turn has been shown to induce the production of 
the antiapoptotic protein cIAP2 (Sears, 2009). The possibility of the certain B. fragilis strains 
having oncogenic potential further demonstrates the importance of this organism as a health 
threat. 
 
16 
 
 
Figure 1.1.  Model fo r the pathogenesis of ETBF (Sears, 2001). See text for details.  
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It has already been shown that the ability of bacteria to adhere to the host is considered important 
for virulence. Proteolytic activity can also have a severe impact on the host, as described in this 
last example. This thesis focuses on the ability of B. fragilis to adhere to and degrade 
components of the host extracellular matrix and how this may rela te to virulence. This is 
discusses in detail in the following sections.  
 
 
1.2 BACTERIAL INTERACTIONS WITH THE HOST EXTRACELLULAR MATRIX 
(ECM) 
 
In addition to the B. fragilis virulence factors that have been described in the previous section, 
the interaction of the bacterium with the host extracellular matrix (ECM) is also thought to play a 
major role in tissue invasion and pathogenesis. These interactions can involve both adhesion to 
components of the ECM as well as their degradation as part of a process of colonization and 
tissue invasion. This aspect is the major thrust of the work described in this thesis and will be 
reviewed below. 
 
1.2.1 THE HOST ECM 
 
The host ECM is an intricate network of macromolecules that underlies the epithelial and 
endothelial cells and surrounds connective tissue cells (Alexander et al., 1991). Based on its 
composition, this biologically active tissue not only serves a structural function, but is also 
involved in processes like cellular adhesion, migration, proliferation and differentiation 
(Alexander et al., 1991). The macromolecules that make up the ECM are divided into four main 
classes, namely glycoproteins, proteoglycans, elastin and collagens (Figure.1.2).  
 
The ECM allows for the adhesion of the host‟s cells in physiological conditions, but it also 
serves as a substrate for the attachment of microorganisms (Patti et al., 1994). Attachment is 
considered a crucial first step in the infective process. The following sections of this review will 
deal with the molecular mechanisms involved in adhesion and degradation of some of these 
ECM components. The importance of these interactions and their relevance to bacterial and       
B. fragilis pathogenesis will be highlighted.  
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Figure 1.2. The basic structure of the extracellular matrix. (Alberts et al., 2008a). 
 
 
1.2.2 ADHESION AND PROTEOLYIS 
 
1.2.2.1 ADHESINS 
 
The attachment of bacteria to the ECM is mediated by what are known as microbial surface 
components recognising adhesive matrix molecules (MSCRAMMs) (Patti et al., 1994). As the 
name implies, these adhesins are expressed on the surface of bacteria. In gram negative bacteria, 
like B. fragilis, these are often part of surface structures such as fimbriae and pili, although major 
surface proteins, like YadA of certain Yersinia species, can also mediate adhesion (Patti et al., 
1994).  Certainly in     B. fragilis, surface appendages have been shown to mediate adhesion to 
human cells lines (Pumbwe et al., 2006). MSCRAMMs are able to bind components of the ECM 
that are either full time ECM residents, like collagen and laminin, or part-time molecules like 
fibrinogen and fibronectin (Patti et al., 1994). The adhesion must be of high affinity and often a 
high degree of specificity is found, although adhesins with the ability to bind multiple ECM 
components have been reported. 
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Although schematic models of MSCRAMMs have been developed, based on the characteristics 
of Staphylococcus aureus adhesins, there is not a great deal of information available about the 
general structural features of theese adhesins (Patti et al., 1994).  Some conserved domains have 
been identified, and they include a signal sequence at the amino-terminal end of the protein, as 
well as a cell wall spanning domain, a hydrophobic membrane spanning domain and a positively 
charged carboxyterminus (Figure. 1.3). A unique or variable region is found in between the 
signal sequence and the rest of the conserved domains. This is thought to be specific for each 
adhesin. 
 
 
 
 
Figure 1.3. Model of MSCRAMM domains. (S) signal sequence; (U) unique sequence; (W) cell wall 
spanning domain; (M) hydrophobic membrane spanning domain; (C) and a positively charged 
carboxyterminus. (Based on models described by Patti et al., 1994). 
 
 
1.2.2.2 PROTEASES 
 
Proteases are enzymes that hydrolyse proteins into their amino acid components. Those enzymes 
produced by bacteria can be highly specific to a particular substrate or have the ability to degrade 
a plethora of proteins. Bacteria can use proteases for nutrient generation by degrading the host 
tissue, like the ECM, but this destruction also allows for the bacteria to invade and colonise the 
tissue (Supuran et al., 2001; Travis and Potempa, 2000). Proteases are important virulence 
factors not only because of their involvement in tissue destruction, but also because they help the 
microorganism to evade the host defences and deregulate important host cell processes, therefore 
making them critical for the survival and proliferation of the pathogen (Lebrun et al., 2009). 
 
 
 
S                                      U                                        W        M      C 
20 
 
Extensive research has been done on proteases and their classification is well described. Three 
levels of protease classification have been established by the International Union of 
Biochemistry and Molecular Biology (IUBMB). The first is based on the type of reaction that is 
catalysed, the second on the sequence specificity and the third on the chemical nature of the 
catalytic site (Barrett, 2001; Rao et al., 1998).  
 
The type of reaction catalysed relates to the position of bond hydrolysed, namely whether it is 
near one of the ends of the peptide chain or internal to the peptide. These are called exo- and 
endopeptidades respectively, peptidase being and alternative name for protease (Table 1). The 
complete digestion of proteins into their amino acid components requires the action of both 
endo- and exopeptidases (generally in that order). This is due to the fact that protein molecules, 
which are usually hundreds of amino acids long, have only two ends on which exopeptidases can 
act. Therefore, the initial protein degradation is done by endopeptidades, with exopeptidases 
completing the breakdown into amino acids.  
 
               Table 1. Types of Protease reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arrows show the cleavage sites. Dark blue circles are terminal amino acids. Light blue circles 
are internal amino acids. Dark blue triangles denote a variable number of terminal amino acids.  
 
Protease  Action 
Exopeptidases  
Aminopeptidase  
 
Dipeptidyl-peptidase 
 
Tripeptidyl-peptidase 
 
Carboxypeptidase  
 
Peptidyl-peptidase  
 
Dipeptidase  
 
Omega peptidase  
 
Endopeptidases  
Serine, Cysteine ,Aspartic, 
Threonine & Metalloproteases 
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The sequence specificity of proteases relates to the preference of difference enzymes for specific 
amino acid residues surrounding the target peptide bond. 
 
In addition, five catalytic types of proteases are known, namely serine, cysteine, aspartic, 
threonine and metalloproteases (Barrett, 2001). Serine proteases have a catalytic site in which the 
side-chain hydroxyl group of a serine residue forms a transient acyl enzyme intermediate during 
catalysis. The „catalytic triad‟ of these enzymes is usually composed of a histidine, which acts 
together with the serine, and an aspartate residue. They do not normally require cofactors and 
have optimal activities at neutral or slightly alkaline pH values. Threonine proteases have a 
threonine residue that is involved in forming the transient acyl intermediate. Similarly to the two 
previously mentioned catalytic types, cysteine or thiol proteases have a cysteine residue in which 
is the thiol group is the nucleiophillic group. Aspartic proteases have two aspartic residues, one 
in each of the two lobes of the enzyme which activate a water molecule which is directly 
involved in the hydrolyisis of the peptide bond. Metalloprotease activity is dependant on the 
presence of a divalent metal ion bound at the active site with the general motif of His-Glu-Xaa-
Xaa-His (HEXXH). 
 
Unfortunately the IUBMB protease classification only allows for a small number of groups 
under which proteases can be classified. This results in enzymes that have significant differences 
being grouped together. The classification is also not useful in predicting the properties of 
proteases.  The MEROPS system (Rawlings et al., 2010) overcomes this by grouping proteases 
into families based on statistically significant similarities between amino acids believed to be 
important for catalysis. Families that appear to have evolved from a singles peptidase, as 
determined by three-dimensional structure comparisons or amino acid sequence motifs, are then 
clustered into clans (Barrett, 2001).  
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1.2.2.3   INHIBITION OF ADHESION AND PROTEOLYSIS AS A POTENTIAL  
 THERAPEUTIC METHOD 
 
The relevance of adhesins and proteases as virulence factors has been discussed. Inhibition of 
both the adhesive and proteolytic properties of organisms has been examined as a potential 
therapeutic method, and a few strategies for preventing adhesion have been reviewed by Barczak 
and Hung (2009). In gram positive bacteria, inhibition of sortases is considered a promising 
strategy as these enzymes are responsible for the localization and anchoring of proteins, 
including adhesins, to the cell wall. However, no in vivo studies have been performed. In Gram 
negative bacteria, where adhesion is primarily attributed to the pili and fimbrae, inhibition of the 
formation of these structures and/or competition for binding sites are the main strategies 
proposed. The effect of pillicides, which prevent pili formation, has been assessed in vitro and 
shown to prevent hemagglutination of E. coli and a number of synthetic and natural ligands of 
fimbrae have been shown to block adhesion (Dobrindt and Hacker, 2008). 
 
The inhibition of proteolytic virulence targets is a much more developed field. The importance of 
proteases to bacteria as virulence factors, as well as in cell regulatory mechanisms and for 
nutrition, makes them attractive drug targets. It also appears that the structure of various bacterial 
proteases, where they are known, show significant differences from those of the human host 
(Travis and Potempa, 2000). This is of extreme importance in drug design making proteases 
attractive targets. Although inhibitors of viral proteases are in use, like for example the HIV-1 
protease inhibitor, there is still very little progress in the design of bacterial protease inhibitors 
for use as antibiotics (Supuran et al., 2001; Travis and Potempa, 2000). At least one bacterial 
collagenase inhibitor study has been conducted  in which potent Clostridium histolyticum 
collagenase inhibitors were analysed in vitro (Scozzafava et al., 2000).  
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1.2.3 ADHESION TO, AND PROTEOLYSIS OF, SPECIFIC COMPONENTS OF THE 
HUMAN ECM  
 
1.2.3.1  GLYCOPROTEINS 
 
Glycoproteins are proteins covalently bound to oligosaccharide chains (Alberts et al., 2008b). 
Examples of these include laminin and fibronectin. Laminin occurs is over 15 isoforms and 
together with collagen type IV (see later sections) form networks that are the central part of the 
basal lamina, or basement membrane (Sasaki et al., 2004). The basal lamina is a specific ECM 
that underlies epithelia and endothelia. Fibronectin has two forms, a soluble one found in plasma 
(pFn) and an insoluble form (Alexander et al., 1991). It is essential for the adhesion of 
eukaryotic cells and is in involved in wound healing (Alexander et al., 1991) 
 
B. fragilis has been shown to adhere to both laminin and fibronectin (Ferreira et al., 2006; Pauer 
et al., 2009; Szoke et al., 1997). Laminin binding was attributed to adhesin(s) found in the outer-
membrane fraction which were hypothesised to be glycoproteins due to the loss of adhesion 
observed after treatment with meta-sodium periodate (Ferreira et al., 2006). An adhesin of 
approximately 102 kDa, with the ability to bind pFn was purified and protein sequenc ing 
revealed it to be a putative TonB-dependent outer membrane protein (Pauer et al., 2009).  
 
To date, no proteases with the ability to degrade either of these ECM glycoproteins have been 
discovered for B. fragilis. However, various other pathogens do degrade both laminin and 
fibronectin. Some examples include the anaerobic bacteria Clostridium difficile and Clostridium 
perfringens which produce a cysteine and a metalloprotease, respectively, which degrade both 
substrates (Janoir et al., 2007; Jin et al., 1996).  
 
The gram-negative oral pathogen, Porphyromonas gingivalis, like various Clostridium species, is 
also a notorious protease producer which causes extensive tissue damage. The main virulence 
factors of this bacterium are known as gingipains (O'Brien-Simpson et al., 2003). These are 
arginine and lysine specific proteases encoded by the genes rgpA, rgpB and kgp. They have been 
24 
 
reported to degrade laminin, fibronectin, fibrinogen and collagens type I, III, IV and V. 
Furthermore, the RgpA and Kgp proteases have C-terminal domains that are responsible for 
adhesion to laminin and fibronectin as well as fibrinogen and collagen type V (see below). This 
extraordinary organism is a good model for many of the ECM adhesion and degradation 
properties to be described in this thesis. 
 
 
1.2.3.2  PROTEOGLYCANS 
 
These molecules are highly glycosylated proteins composed of a core protein covalently attached 
to glycosaminoglycans (GAGs) (Alexander et al., 1991). These include molecules like heparin 
and fibrinogen, both of which are essential components of blood clotting mechanism and wound 
healing. Fibrinogen is the soluble precursor to insoluble fibrous protein fibrin which binds 
platelets to form a clot which temporarily plugs a damaged area of a blood vessel (Gannong, 
2001). The clotting and fibrinolytic system is kept is balance by cascades of activators and 
inhibitors, many of which are proteases zymogens (Figure. 1.4). Bacterial proteases have been 
shown to activate many of these during pathogenesis, leading to deregulation of the system 
(Bergmann and Hammerschmidt, 2007; Maeda, 1996).  
 
 
 
 
 
 
 
Figure1.4. Some steps in the formation and dissolution of fibrin clots. (See text for details).  
 
 
Many bacteria can disrupt either the conversion of fibrinogen to fibrin, or the breakdown of the 
fibrin clot. Both of these can lead to impaired coagulation and even bleeding, which can allow 
the bacteria to spread into tissue and into the blood stream causing tissue disruption and 
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septicaemia (Maeda, 1996). Many bacteria have been shown to bind and/or degrade fibrinogen. 
In both cases this protein is no longer available for the formation of fibrin. As mentioned in the 
previous section, gingipains of P. gingivalis have been shown to have just such an effect, which 
leads to binding and invasion of tissue as well as vascular disruption, or bleeding (O'Brien-
Simpson et al., 2003).  
 
B. fragilis has also been shown to adhere and degrade fibrinogen. A serine-thiol- like protease of 
approximately 100 kDa was shown to degrade fibrinogen, case in, azocasein, gelatine and azocoll 
but had no activity against proteins like fibrin, fibronectic and collagens type I, II and IV (Chen 
et al., 1995). In an initial study, the B. fragilis 20 kDa enterotoxin (BFT) also demonstrated the 
ability to degrade fibrinogen (Moncrief et al., 1995). However, a subsequent study (Wu et al., 
2002) revealed that that BFT protein preparation had in fact not been pure and, although this was 
never re-tested, the activity described against the protein substrates may not be attributable to 
BFT. Recently, Houston et al. (2010), have reported the discovery of extracellular 
fibrinogenolytic activity at about 45 and 50 kDa using zymography. These were determined to 
have metalloprotease activity in B. fragilis strains NCTC9343 and 638R, and mild cysteine 
protease activity in YCH46, demonstrating the variations observed between different strains of 
the same species. Neither the 100 kDa or the 45 and 50 kDa protease activities have as yet been 
linked to specific genes. However, a 54 kDa fibrinogen binding protein (BF-FB) has been 
identified and characterised (Houston et al., 2010). 
 
It is worth mentioning here, in the context clotting and fibrinolysis, that a plasminogen binding 
protein (Bfp60) has been described in B. fragilis (Sijbrandi et al., 2008). Interestingly, this 
adhesin was also found to bind laminin (Ferreira et al., 2009). Furthermore, the recombinant 
Bfp60 was able to activate plaminogen to plasmin to levels comparable to the known 
plasminogen activator, streptokinase. The ability to degrade fibrin and/or prevent its formation, 
by fibrinogen elimination, can have huge consequences for the pathogenicity of B. fragilis. 
Abscesses, which are characteristic of this bacterium‟s infection, are mainly composed of a thick 
fibrin wall, and preventing its formation or disrupting it can allow the bacterium to disseminate 
in the host (Houston et al., 2010).  
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1.2.3.3  ELASTIN 
 
Elastin is a fibrous polymeric protein which offers tissue flexibility (Alexander et al., 1991). It is 
a polymer of cross-linked tropoelastin precursor molecules and is the main component of elastic 
fibres. The adhesion to and degradation of this substrate by bacteria has been reported in 
association with various pathologies like cystic fibrosis associated pulmonary infections 
(Spencer et al., 2010). Pseudomonas aeruginosa, infections are the leading cause of death in 
cystic fibrosis patients. This bacterium produces an endopeptidase, LasA, which is responsible 
for the degradation of elastin and heparan sulphate proteoglycan syndecan-1 and is considered an 
important virulence factor (Spencer et al., 2010).  LasA has similarities to the S. aureus 
lysostaphin protease which is also known to adhere to elastin (Park et al., 1995). Fibrinogen 
binding protein A (FnBPA) is another S. aureus adhesin that can also bind elastin and is an 
example of this bacterium‟s multi- functional MSCRAMMs (Keane et al., 2007). 
 
Little is known of the relationship of B. fragilis to elastin. Gibson et al. (1988b) reported the 
strains assayed to be unable to use this protein as a substrate, whereas a more recent study 
looking at elastase activity of anaerobes from a samples of preterm premature ruptured 
membranes, found that 15 of the 28 B. fragilis strains could degrade elastin (Mikamo et al., 
1999). 
 
Collagen, like elastin, is a fibrous protein component of the ECM. In fact, it is the predominant 
component of the ECM and, as the primary focus of this study, is discussed in detail in the 
following section. 
 
 
1.3 COLLAGENS 
 
Collagen is the major component of the ECM and is in fact the most abundant protein in 
mammals, accounting for 25 to 33% of all proteins (Harrington, 1996; Watanabe, 2004). It is the 
main component of skin, tendons and cartilage, as well as being the organic component of bones, 
teeth and cornea. Collagen gives tissues their strength and structure and is found in the 
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connective tissues of nearly all organs. The ability of bacteria to interact with it is, therefore, 
important for commensals and especially for pathogens.  
 
 
1.3.1 COLLAGEN STRUCTURE AND TISSUE TROPISM 
 
Collagens are long (approximately 300 nm), rod-like molecules made up of three parallel 
polypeptide chains, each of which has the left-handed helix (Cunningham and O'Connor, 1997). 
This type of helix is seen when proline residues occur sequentially. Proline is an amino acid 
which is unique amongst the other nineteen amino acids in that it has a pyrrolidine ring structure 
as its side chain (Figure. 1.5). This cyclic structure imposes constraints on the rotation of the N-
Cα peptide bond, making this peptide bond one of the most difficult to hydrolyse. Another 
consequence of this cyclic nature is that there are no functional groups from which H-bonding 
may occur. Proline is thus the only amino acid that cannot participate in the formation of α-
helices or β-sheets.  
 
 
(A)                                                              (B) 
 
 
 
Figure 1.5. Structural characteristics of (A) general amino acids and (B) proline. (Cunningham and 
O'Connor, 1997)  
 
The three left-handed helices twist around a common axis making a major helix that is slightly 
right handed. A common amino acid sequence, Gly-X-Y, is found in the triple helix, where the X 
and Y are often proline and hyroxy-proline (Alexander et al., 1991). The triple helix is stabilized 
by the presence of hydrogen bonds between the chains as well as by inter- and intramolecular 
cross- links. Figure 1.6 below shows a schematic view of these levels of organization.  
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Figure 1.6. Schematic diagram of the levels of organization of collagen structure from the alpha chain to 
the collagen fibril. Based on previously described data (Orgel et al., 2000) 
 
 
At least 25 distinct collagen encoding genes and 19 collagen molecules have been discovered in 
humans (Watanabe, 2004).  These differ in terms of their length, degree of hydroxylysine 
glycosylation and ratios of hydroxylated and non-hydroxylated residues (Harrington, 1996). The 
classical fibrillar collagens, made of a continuous triple helix with non-helical ends, are types I, 
II, III, V and IX. Type IV is composed of many more non-helical regions and it assembles to 
form tetramers, which can in turn interact to form collagen sheets via globular domains  
(Harrington, 1996). The different types of collagen are distributed in particular areas of the body. 
The most abundant collagen is type I which has been isolated from various connective tissues 
from cornea and skin to tendons and bone (Alexander et al., 1991). Other fibrillar types are also 
found in a variety of tissues. The non-fibrillar, or network-forming, type IV collagen is found in 
the basal lamina. This variety of structure and tissue tropism means that an equally diverse set of 
bacterial adhesins and proteases can occur.  
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1.3.2 COLLAGEN ADHESINS IN BACTERIA 
 
Adhesins with the ability to bind multiple forms of collagen have been described, as well as 
those specific to a single form (Patti et al., 1994). The MSCRAMMs of S. aureus were some of 
the first to be studied. The Cna, collagen binding protein mediates the adhesion of S. aureus to 
collagen (Foster and Hook, 1998). The “unique” domain (see section 1.2.1) of this 55 kDa 
adhesin is a 19 kDa domain which has been shown to bind to different collagen types. Structural 
studies have shown that it binds to multiple binding sites of a collagen triple helix. Interestingly, 
not all strains of S. aureus express Cna. 
 
The yadA gene, encoding the YadA protein, has been found on a virulence plasmid of some 
pathogenic Yersinia spp (El and Skurnik, 2001). YadA binds not only to various collagen types 
(I, III, IV and V), but to other ECM proteins as well, such as laminin and fibronectin. In Y. 
enterolytica, the YadA mediated collagen adhesion has been found to be necessary in order for  
virulence to occur (El and Skurnik, 2001).  
 
 
1.3.3 BACTERIAL COLLAGENASES 
 
The ability of bacteria to adhere to collagen has already been shown to be important for 
virulence. Collagenolytic enzymes produced by some bacteria have similarly been identified as 
crucial virulence factors (Watanabe, 2004).  
 
The study of collagenases is relevant to human health due to the large range of diseases 
associated with collagenolytic bacteria (Harrington, 1996). The focus of this discussion will be 
on diseases caused by anaerobic bacteria, which often occur in tissue due to poor blood supply to 
the area. Other predisposing factors to these infections include wound formation after trauma or 
surgery, malignancy, tissue necrosis and severe aerobic microbial infection. The last factor 
results in a decrease in the redox potential of the site allowing for the proliferation of anaerobic 
bacteria. The production of degradative enzymes, like collagenase, also allows bacteria to 
penetrate further into the tissue.  
30 
 
Collagenolytic bacteria cause diseases in various anatomical sites. Soft tissue is of particular 
interest to us due to the nature of B. fragilis infection sites. Clostridial collagenases were the first 
to be described and are used as a comparison for any new collagenases. C. perfringens causes 
necrotising diseases like clostridial myonecrosis, otherwise known as gas gangrene. C. 
histolyticum can also cause myonecrosis and is known to produce more than five 
electrophoretically different collagenases. Several oral pathogens have also been shown to be 
collagenolytic. P. gingivalis which has been discussed throughout this chapter is a good example 
of a highly collagenolytic pathogen.  
 
When referring to enzymes that cleave collagen, also known as collagenolytic proteases, two 
basic types are generally recognised. True collagenases digest collagen macromolecules in their 
fibrillar form, and non-true collagenases recognize and cleave collagen specific sequences which 
can be found, for example, in gelatin and the synthetic collagenase substrate Pz (4-
phenylazobenzyloxycarbonyl)-Pro-Leu-Gly-Pro-D-Arg (Pz-PLGPR) (Harrington, 1996). The 
two types are relatively hard to differentiate. In general, it is likely that most collagenases in the 
human body can degrade both collagen and gelatin. This is due to the fact that, at body 
temperature, the thermodynamically preferred conformation of collagen is not the helical form 
but rather a random coil (Watanabe, 2004). 
 
Mammalian matrix metalloproteinases (MMP‟s) have been extensively studied and a large 
amount of structural detail is known (Watanabe, 2004). By comparison, although collagenolytic 
activity has been described for numerous bacteria, detailed molecular information is limited. 
Collagenases are mostly extracellular or cell surface associated enzymes of various catalytic 
types. Most described collagenases are either metallo- or serine proteases, although cystein or 
thiol proteases have also been observed.  
   
Collagen-binding domains have been identified in mammalian matrix metalloproteases (MMP‟s) 
and in some bacterial collagenases, although there are no similarities between the protein 
sequences of the domains from the two sources (Watanabe, 2004). The collagen binding 
proteases of P. gingivalis have already been mentioned. However, gingipains are not specific to 
collagen. Examples of specific enzymes include ColH and ColG of C. histolyticum (Matsushita 
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et al., 1999; Yoshihara et al., 1994), ColA of Clostridium perfringens (Matsushita et al., 1994) as 
well as a Geobacillus collagenovorans collagen binding collagenase of approximately 105 kDa 
(Itoi et al., 2006). These double facetted enzymes could be very significant virulence factors, but 
several other bacterial collagenases lacking binding domains have also been described 
(Watanabe, 2004). 
 
 
1.3.4 B. FRAGILIS AND COLLAGEN 
 
Surprisingly little research has been done on the interactions of B. fragilis with collagen. The 
ability of this bacterium to bind to collagen has been tested against abundant fibrillar collagen 
type I, and a preparation of type I mixed with type III (Szoke et al., 1996; Szoke et al., 1997). 
The first study showed that strains of B. fragilis had the ability to bind collagen type I and that 
this was associated with proteinaceous receptors on the cell surface of the organisms (Szoke et 
al., 1996). In the second study, 15 of the 24 B. fragilis isolates from infected sites and 9 out of 
the 13 of strains isolated from faecal material were found to be able to adhere to collagen type I 
(Szoke et al., 1997). This means that adhesion is likely to be strain specific.  
 
Early studies on the ability of B. fragilis to degrade various protein substrates, showed that it was 
unable to degrade gelatin, collagen type V or azocoll (diazotized collagen) under the conditions 
tested (Gibson and Macfarlane, 1988b). Later studies revealed the presence of proteases that 
could degrade gelatin but were refractory to collagens type I, II, III and VI (Patrick, 2002). As 
mentioned previously a 100 kDa fibrinolytic, serine-thiol- like protease, of B. fragilis did show 
activity against gelatine and azocoll but none against other collagens (Chen et al., 1995). 
Similary, the B. fragilis enterotoxin (BFT) also showed some activity against azocoll (Moncrief 
et al., 1998).  
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Table 1.2: Summary of interaction of B. fragilis with components of the ECM. 
ECM component Adhesion Reference Degradation Reference 
Fibronectin (+) 
Bfp60 (60 kDa) 
Szoke et al., 1997 
Ferreira et al., 2009 
(-) Patrick, 2002;  
Chen et al., 1995 
Laminin (+) 
Putative TonB-dependent 
outer membrane protein 
(102 kDa) 
 
Szoke et al., 1997 
Ferreira et al., 2006; 
Pauer et al., 2009 
(-) Patrick, 2002;  
Chen et al., 1995 
Fibrinogen (+) 
BF-FB (54 kDa) 
Houston et al., 2010 (+) 
(100kDa) 
BFT (20 kDa)?  
45 kDa 
50 kDa 
 
Chen et al., 1995 
Moncrief et al., 1995 
Houston et al., 2010 
Elastin NT  (+) Gibson et al., 1988b  
Collagens  
Type I 
Type II 
Type III 
Type V 
Type VI 
 
(+) 
NT 
NT 
NT 
NT 
 
Szoke et al., 1997 
 
(-) 
(-) 
(-) 
(-) 
(-) 
 
 
 
Gibson and MacFarlane, 
1988b 
 (+): Able to adhere/degrade ECM component; (-): Unable to adhere/degrade ECM component: NT: not 
tested. Where an interaction has been attributed to at least one protein this has been stated.  
 
In this chapter a review of the importance of B. fragilis as commensal and an opportunistic 
pathogen has been presented. As a commensal it has been shown to aid in digestion and to 
stimulate the host immune system (Patrick, 2002; Round and Mazmanian, 2010). Our interest, 
however, is focused on the threat that the bacterium poses to human health and on the importance 
of discovering novel therapeutic strategies, such as anti-virulence drugs, to combat the disease 
caused by the microorganism. The ability of bacteria to bind and degrade components of the host 
ECM is considered an important virulence trait (Pauer et al, 2009). Several of these interactions 
have been studied in B. fragilis and are summarized in Table 1.2. B. fragilis has been shown to 
bind most of the ECM components, and to degrade some these. It, therefore, seems unlikely that it 
should have such a limited relationship with the predominant ECM component, collagen. We 
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hypothesise that the interactions with collagen may be collagen type and bacterial strain specific. 
Only about 60 to 70 % of the strains tested in a previous study were found to adhere to collagen 
type I (Szoke et al., 1996; Szoke et al., 1997). A similar situation may occur for the production of 
collagen proteases and it is, therefore, relevant to further explore the ablity if the bacterium to 
interact with this substrate. 
 
1.4 AIMS AND OBJECTIVES 
 
In this dissertation the general aim was to investigate further the relationship of B. fragilis with 
the collagen type that it has been shown to adhere to, namely type I, with the specific objectives 
being the following: 
 
Objective 1: to determine if B. fragilis produces any proteases with the ability to digest collagen 
type I. 
 
Objective 2: to assess the relative collagen affinity of several South African clinical isolates of           
B. fragilis in order to find the best strain for further investigation. 
 
Objective 3: to investigate the presence of specific collagen type I proteases and adhesins using 
molecular techniques. 
 
Objective 4: to identify the various collagenases and collagen type I adhesins using 
bioinformatic and proteomic techniques, taking advantage of the availability of the full genome 
sequences of three different B. fragilis strains to specifically identify genes encoding these 
proteins. 
 
Objective 5: to genetically and functionally characterise a gene encoding a putative collagen 
adhesin. 
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2.1 INTRODUCTION  
 
B. fragilis has previously been demonstrated to adhere to collagen type I (Szoke et al., 
1997). The first aim of this study, therefore, was to test whether B. fragilis also had the 
ability to degrade collagen type I and to identify the proteases responsible for this 
activity. Various methods exist for the identification of bacterial protease genes. 
Choosing an appropriate strategy depends on the type of protease and the substrate of 
interest, and proteases can range from highly substrate-specific enzymes to those with the 
ability to hydrolyze numerous substrates. Identification of the more promiscuous types 
can be done by screening for activity using a general protein substrate such as casein or 
its dye conjugated version, azocasein. Generally, there are two types of collagenases: 
those known as true collagenases, which only degrade fibrillar collagen, and non-true 
collagenases that recognize and cleave collagen specific sequences which can be found in 
relatively inexpensive substrates such as gelatin (Harrington, 1996).  
 
Traditionally, the simplest way of identifying genes encoding functional proteases is by 
creating a gene bank of the subject bacterium in E. coli and screening clones for their 
ability to degrade a general protease substrate, such as casein, on an agar plate assay 
(Takahashi et al., 1991). Gelatin plates could also be used as a more specific substrate for 
screening for collagenase genes. This method can, however, be somewhat limiting as it 
can only be used to detect non-true collagenases. Furthermore, expression of B. fragilis 
genes in E. coli is often weak or altogether unsuccessful. This is thought to be due to 
differences in the promoter structures between the two bacteria (Bayley et al., 2000). 
Various B. fragilis promoters have been shown to have a -7 region with a consensus 
sequence of TAnnTTTG, and upstream, at about -33, a TTTG sequence is also found. 
This differs from the typical -10 and -35 promoter consensus sequences of E .coli.  For 
these reasons, in this study, the production of a gene bank and expression of possible 
recombinant proteases was not thought to be the most appropriate  approach to the 
identification of collagenase genes. 
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Another commonly employed strategy is the creation of mutants of the bacterium of 
interest, followed by screening for the loss of activity (Bonifait et al., 2010). Again, there 
are limitations associated with the screening method. Not only does one require a 
relatively inexpensive and simple assay to screen large numbers of mutants, but if there 
are multiple proteases with similar substrate specificities being produced by the 
bacterium, these may mask the absence of a mutated one.  
 
An alternative approach is to combine functional analysis of the protease activity with 
bioinformatic prediction of the genes involved. In using this strategy, the first step in 
identifying the collagenase genes of B. fragilis required the assessment of the bacterium‟s 
ability to degrade collagen. Commonly used collagenous substrates include various types 
of fibrillar collagens, as well as gelatin and synthetic peptide analogs of collagen like 
phenylazobenzyloxycarbonyl-L-leucylglycyl-L-prolyl-D-arginine (PZ-PLGPA) and 2-
furanacryloyl-L- leucylglycyl-L-prolyl-alanine (FALGPA).  Zymograms, or activity gels, 
that have been either co-polymerised, overlaid or soaked with the substrate of choice are 
a particularly useful technique to use to show the ability of a bacterium to degrade the 
substrate, and for identifying the number and relative protein sizes of the proteases 
present. Collagen has been used for this type of assay and this is an excellent approach 
for identifying proteases that can degrade the fibrillar form of this substrate (Phillips et 
al., 2000).  
 
Once the sizes of the proteins of interest have been determined, identification of the 
putative genes responsible for their production can be done by two methods. One is the 
isolation and purification of the proteins of interest, followed by the determination of the 
protein sequence by methods like N-terminal amino acid sequencing or MALDI-
TOFTOF MS (MS/MS) analysis. Alternatively, bioinformatic gene mining for putative 
protease genes of appropriate sizes to those showing activity can be done. Both of these 
approaches were considered viable options for this study due to the availability of the 
complete genome sequence and annotation of various B. fragilis strains, including B. 
fragilis 638R which is used in this study.  
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The aims of the work reported in this chapter were, therefore, to use protein gel 
zymography to determine whether B. fragilis expressed proteases with the ability to 
degrade collagen Type I and to determine their protein sizes. This information was then 
used to examine the published B. fragilis genome sequence to identify potential candidate 
genes for further study. 
 
 
2.2 MATERIALS AND METHODS 
 
2.2.1 BACTERIAL STRAINS AND GROWTH CONDITONS 
 
All B. fragilis strains described in Table 2.1 were routinely cultured in Difco brain heart 
infusion, supplemented with hemin (5 µg/ml), menadione (0.5 µg/ml) and cysteine (0.5 
µg/ml) (BHIS) agar and broth (Holdeman and Moore, 1972).  B. fragilis was grown 
under anaerobic conditions in an anaerobic chamber (Model 1024, Forma Scientific Inc., 
Marietta, Ohio) with atmospheric conditions of oxygen-free N2, CO2 and H2 (85:10:5 by 
vol). For the selection of transconjugants following mutagenesis (see Section 2.2.11 
below), B. fragilis 638R mutants were cultured on BHIS agar including gentamycin (200 
µg/ml), rifampicin (20 µg/ml) and erythromycin (10 µg/ml). E. coli strains were grown in 
Luria-Bertani (LB) broth or agar, aerobically, at 37°C  (Maniatis et al., 1982). Strains 
harbouring plasmids were supplemented with ampicillin (100 µg/µl).  
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Table 2.1. Description of bacterial strains and plasmids 
Strain/Plasmid Genotype/phenotype Source/reference 
Plasmids   
pGERM pUC19-based suicide vector (Shoemaker et al., 2000) 
pGERMclg-int pGERM containing the BF638R internal fragment This study 
Strains   
Bacteroides fragilis   
638R Clinical strain, Rif
R
 Gent
R
 (Privitera et al., 1979) 
638R clg
-
 638R derivative, clg
-
, Gent
R
Erm
R
 This study 
Escherichia coli   
S17-1 RP4-2-Tc::Mu aph::Tn7recA
-
, Strep
R
 (Simon et al., 1983) 
S17-1 pGERMclg-int RP4-2-Tc::Mu aph::Tn7recA
-
, Strep
R
Amp
R
 This study 
S17-1 pGERMclos-int RP4-2-Tc::Mu aph::Tn7recA
-
, Strep
R
Amp
R
 This study 
RifR, GentR, ErmR, StrepR and AmpR denote resistance to rifampin, gentamycin, erythromycin, streptomycin 
and ampicillin respectively. 
 
 
2.2.2 PROTEOLYTIC ACTIVITY OF B. FRAGILIS  
 
B. fragilis 638R was grown in BHIS broth for a period of 40 h. Samples were collected at 
16, 24 and 40 h, and bacterial cells were harvested in pre-weighed eppendorf tubes by 
centrifugation at 14 000 rpm (16 000 g) in an Eppendorf 5415C bench top centrifuge (15 
min). The cell pellets were then dried for 16 h at 65°C and the dry cell mass weighed. At 
these same time points, 2 ml samples were collected and stored at -20°C until the 40 h 
growth period was complete. Each sample was then thawed and cells were collected by 
centrifugation, washed in 0.1 M sodium phosphate buffer pH7.4 and resuspended in 2 ml 
of the same buffer.  
 
The cell bound proteolytic activity of B. fragilis was analyzed against azocasein using a 
modified method based on Gibson and Macfarlane (1988). Each sample collected was 
divided into four 0.5 ml aliquots (three technical replicates and one blank). To three of 
these tubes 0.1 ml 0.1 M sodium phosphate buffer pH7.4 and 0.15 ml azocasein solution 
(10 mg/ml azocasein made up in 0.1M sodium phosphate buffer pH 7.4) was added and 
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incubated for two hours at 37˚C. The reaction was then stopped by addition of 0.5 ml of 
10% Trichloroacetic acid (TCA). After 30 min at room temperature (RT) the tubes were 
centrifuged and 0.5 ml of the supernatant was added to 0.5ml of 1M NaOH and the 
OD450nm was measured. The fourth tube contained the sodium phosphate buffer pH7.4 
and azocasein solution added after the 2 hour incubation period, just before the addition 
of TCA and was used as a blank. One unit of protease activity per mg of dry cell (U/mg) 
was defined as an increase in absorbance of 0.1 OD units at 450 nm after 2 h at 37 °C.  
 
 
2.2.3 STATISTICAL ANALYSIS 
 
The growth and azocasein experiments were performed on three biological replicates. 
The data for these are represented as the mean of the three replicates and error bars of the 
standard error are displayed. To analyse the experimental variance an unpaired, two-
tailed Student‟s t-test was used. The means were only considered significantly different 
when a P value of 0.05 or less was obtained by the test.  
 
 
2.2.4 PROTEIN SAMPLE PREPARATIONS 
 
B. fragilis 638R was grown anaerobically for 16 h to late log/early stationary phase in 
BHIS broth. The cells were harvested by centrifugation using a Beckman JA-14 rotor (10 
000 rpm or 9600 g, 4°C, 15 min), and washed twice in 1 x phosphate buffered saline 
(PBS), pH7.4, by centrifugation using a Beckman JA-14 rotor (10 000 rpm or 9600 g, 
4°C, 5 min each). The pellets were then resuspended to a tenth of the original culture 
volume with PBS and the cells were disrupted by sonication using a Misonic sonicator 
3000 at a power output of 3 W for 5 rounds of 30 s. Cell debris was removed by 
centrifugation in an Eppendorf 5415C bench top centrifuge (14 000 rpm or 16 000 g, 
4°C, 10 min) and the supernatant cell free extract (CFE) was collected. 
After the cells were harvested for the preparation of CFEs, the cell culture supernatants 
were filtered using a 0.2µm cellulose acetate syringe filter to remove any residual 
bacterial cells. The filtrate was then concentrated approximately 20 fold by pressure 
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filtration through a 10 kDa cut-off membrane in an Amicon stirred ultracentrifugation 
cell (Millipore). This preparation was designated the extracellular fraction (ExC). The 
protein samples were at all times kept on ice or at 4°C to avoid loss of enzymatic activity 
or auto-proteolytic events.  
 
 
2.2.5 PROTEIN QUANTITATION AND SEPARATION  
 
All protein samples used at defined concentrations were quantitated using the Bradford 
method (Bradford, 1976) with the Bio-Rad Protein Assay Dye Reagent Concentrate 
according to the manufacturer's instructions (Bio-Rad Laboratories, cat # 1500- 0006) 
using bovine serum albumin (BSA) (Fermentas) as a standard.  
 
Protein samples were mixed 1:1 with 2 x SDS gel loading buffer without β-
mercaptoethanol (0.125M Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 0.002% 
bromophenol blue) and incubated at room temperature for 10 min prior to application to 
the acylamide gels.  Electrophoresis was done in SDS 10% (w/v) polyacrylamide gels 
(SDS–PAGE) without β-mercaptoethanol (Laemmli, 1970), using a Mini-PROTEAN 
Electrophoresis System (Bio-rad) at a fixed current of 15 mA per gel, and at 
approximately 100 V.  
 
After electrophoresis the separated proteins were visualised by staining with Coomassie 
Brilliant Blue R-250. The molecular weights of the separated proteins was estimated by 
comparison to the prestained PageRulerTM molecular weight marker (Fermentas;  
#SM0671). 
 
 
2.2.6 COLLAGEN ZYMOGRAPHY 
 
Collagen zymograms were performed using collagen type I from calf skin (Elastin 
Products Company Inc.) co-polymerised to SDS polyacrylamide gels (SDS-PAGE) based 
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on previously described methods (Phillips et al., 2000). Briefly, collagen type I was co-
polymerised to a concentration of 150 µg/ml in an SDS–PAGE without β-
mercaptoethanol. After electrophoresis, the SDS was removed from the gel by washing 
the gel twice with 2.5% (w/v) Triton-X100 in distilled water, twice with 2.5% (w/v) 
Triton-X100 in 50 mM Tris-HCl, pH 7.5 and twice in 50 mM Tris-HCl, pH 7.5. The gel 
was then incubated at 37°C for 48 h in Activation buffer (0.1 M Tris-HCl, pH 7.6; 0.4 M 
NaCl; 1.97 mM CaCl2). The SDS removal and activation procedure described is based on 
a method by Houston et al. (personal communication).  Bands of activity were viewed as 
areas of clearing after the gel was stained with Coomassie brilliant blue (Laemmli, 1970).  
 
 
2.2.7 BIOINFORMATIC ANALYSIS  
 
The genome annotations of B. fragilis 638R (Wellcome Trust Sanger Institute – 
www.sanger.ac.uk) and B. fragilis NCTC 9343 (National Centre for Biotechnology 
Information – www.ncbi.nih.gov) were searched for the presence of putative protease 
encoding genes. The predicted protein sequence of these were then submitted for BLAST 
analysis on the MEROPS peptidase database (Rawlings et al., 2010). The protein 
sequences for B. fragilis 638R and Porphyromonas gingivalis W83 were obtained from 
the Wellcome Trust Sanger Institute website and National Centre for Biotechnology 
Information respectively. Protein sequence alignments were performed using DNAMAN 
version 4.13 (Lynnon BioSoft).  
 
 
 
2.2.8 DNA TECHNIQUES 
 
Genomic DNA (gDNA) of B. fragilis 638R was extracted by the high-salt buffer total 
DNA extraction method (Steffens et al., 2010). Plasmids were extracted from E. coli 
strains using the BioSpin Plasmid Extraction Kit (BioFlux). DNA obtained was 
quantitated using a Nanodrop spectrophotometer (NanoDrop® ND-1000). Analysis of 
gDNA, plasmid or polymerase chain reaction (PCR) DNA products was routinely done 
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by electrophoresis on 0.8% or 1% (w/v) agarose gels in Tris-acetate buffer (TAE) with 
ethidium bromide and visualized on a GelDoc-XR UV System (Bio-Rad) (Sambrook et 
al., 2001). Plasmids were transformed into E. coli S17-1 CaCl2 competent cells (Dagert 
and Ehrlich, 1979). 
 
 
2.2.9 GENERAL POLYMERASE CHAIN REACTION (PCR) TECHNIQUES  
 
All PCR analyses were performed using either Supertherm TAQ polymerase (Southern 
Cross Biotechnology) or Kapa ReadyMix (Inqaba Biotech) as per manufacturers‟ 
instructions, and the thermal cycling was performed using a GeneAmp® PCR system 
9700 (Applied Biosystems). The standard PCR parameters used consisted of an initial 5 
min denaturation step at 95°C, followed by 25 cycles of denaturation for 30 sec at 95°C, 
annealing for 30 sec at primer pair specific temperatures, and elongation at 72°C for 
variable time periods. The thermal cycling was then concluded with a 5 min elongation 
step at 72°C.  
 
 
2.2.10 INSERTIONAL MUTAGENESIS 
 
An internal fragment of the clg (BF638R4511) gene, of approximately 0.58 kb, was 
amplified by PCR with primers ColI-F & ColI-R (Table 2.2) at an annealing temperature 
of 51.1°C, for an elongation period of 30 sec. The resulting PCR products were cloned 
into the SmaI site of the suicide vector pGERM (Shoemaker et al., 2000) by blunt cloning 
using standard protocols (Maniatis et al., 1982). Confirmation of insert ligations (to form 
the plasmids pGERMclg- int) was done by sequencing (section 2.2.13) with primer M13F 
(Table 2.2). The plasmids were transformed into E. coli S17 CaCl2 competent cells and 
then transferred from these transformants into B. fragilis by conjugation (Shoemaker et 
al., 2000).   
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Table 2.2 Description of PCR primers 
Name Primer  *Hyb  T° Fragment 
size (kb) 
Description 
ColI-F 
 
ColI-R 
5'-GCTATCCAGGCAGGAGC-3' 
 
5'-CGGACGGTGTAAGCACG-3' 
51.1°C 
 
51.1°C 
0.58 kb  Primer pair amplifies 
an internal fragment 
of BF638R4511 of    
B. fragilis 638R; clg.   
ClgF 
 
ClgR 
5'-GAAAGCCATATTGATGCGGGCTACC-3' 
 
5'-GAAAAGCGGGGTCAGTGACATCC-3' 
57.2°C 
 
57.0°C 
2.1 kb Primer pair amplifies 
the full length 
BF638R4511 gene 
(clg) of B. fragilis 
638R 
M13F 
M13R 
5‟-CGCCAGGGTTTTCCCAGTCA CGAC-3‟ 
5‟-GAGCGGATAACAATTTCACACAGG-3‟ 
60.5°C 
53.7°C 
variable  Universal primers 
(Yanisch-Perron et 
al., 1985) 
*Hyb T°. Hybrid ization temperature 
 
 
2.2.11 CONFIRMATION OF INSERTION 
 
The pGERM plasmid carries the erythromycin resistance (ErmR) gene which is used as a 
selective marker for transconjugants. B. fragilis colonies displaying the ErmR phenotype 
were analysed for the presence of the inserted plasmid by PCR. This was performed 
using the M13F and R primers, which bind to the pGERM vector, together with primers 
for the full length target gene, ClgF and ClgR, at an annealing temperature of 55°C, and 
for an elongation period of 30 sec. Sequencing of these PCR product with the M13 
primers was done by Macrogen Inc., Seoul, Korea. 
 
 
2.3 RESULTS AND DISCUSSION  
 
 
2.3.1 B. FRAGILIS GENERAL PROTEOLYTIC ACTIVITY  
 
In order to determine at which growth stage to assay for collagenase activity a measure of 
collagenase activity over time would have to be determined. Unfortunately our attempts 
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at using the traditional quantitative assays for collagenolytic activity, Azocoll and Pz-
peptide assays, were not successful due to various technical difficulties, including the 
inability to dissolve the insoluble Azocoll which lead to non-reproducible activity 
readings (data not shown). Instead a general protease assay using azocasein was 
performed to establish a general protease activity trend. In a previous study of proteolytic 
activity in B. fragilis (Gibson and Macfarlane, 1988b) it was shown that this bacterium 
displayed the greatest cell bound proteolytic activity between late- log/early stationary 
phase (about 16h growth), and late stationary phase (about 32 h of growth). To establish 
whether there was any significant difference in the general proteolytic activity over a 
similar period of growth, assays of the cell bound azocasein activity of B. fragilis grown 
to 16, 24 and 40 hours were performed (Figure. 2.1 B). It appeared that the highest 
proteolytic activity occurred at 16 h, but statistical analysis showed that there was no 
significant difference (P > 0.05) between the time points analyzed (16 h to 24 h, P = 
0.25; 16 h to 40 h, P = 0.13; 24 h to 40 h, P = 0.30).   B. fragilis 16 h  cultures were, 
therefore, used for further analysis. 
 
 
 
  
                                                                          
      
 
 
 
 
 
 
 
Figure 2.1 General proteolytic activity of B. fragilis 638R in BHIS broth. Mean values ±SD (n=3). 
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2.3.2 COLLAGEN PROTEASES 
 
B. fragilis had been reported to be unable to degrade collagen, as tested against azocoll, 
the azodye conjugated collagen substrate, and collagen type V (Gibson and Macfarlane, 
1988b). However, the proteolytic toxin (BFT) produced by some B. fragilis 
enterotoxigenic strains (ETBFs), did have the ability to degrade azocoll (Moncrief et al., 
1995). Furthermore, B. fragilis is known to be able to bind to collagen Type I (Szoke et 
al., 1997) which means that some interaction between the bacterium and this ECM 
component does occur. Our attempts to use azocoll as a substrate for the reproducible 
quantitative analysis of the ability of B. fragilis to degrade collagen were not successful 
due to technical difficulties encountered in standardizing the amount of the insoluble 
azocoll substrate in the reaction mixture (data not shown). A qualitative approach for 
identifying any collagen degrading proteases was, therefore, used. This involved collagen 
Type I zymography, whereby two cellular fractions, the CFE and ExC fractions, were 
electrophoresed on an SDS-PAGE gel co-polymerised with the substrate (Figure.2.2 A, 
B).  
 
In order to preserve the activity of any putative proteases present in the protein samples 
several precautions were undertaken. Firstly the proteins samples were maintained at 4ºC 
or on ice throughout the sample preparation process. Secondly, no β-mercaptoethanol 
was used in order to prevent the reduction of disulphide bond which could result in the 
loss of formation of enzymatically important protein multimers. The samples were also 
not boiled prior to electrophoresis, a common practice before sample application to SDS-
PAGE gels. Further more all gels were electropheresed at 4ºC to avoid any heat 
denaturation of the proteins. Denaturation of the sample proteins by the SDS detergent 
occurs during electrophoresis. However, it has been shown that renaturation upon 
removal of the SDS is possible by washing the gels with Triton X-100. This was 
performed on the zymograms, therefore allowing for the proteolytic activity to be 
detected. This renaturation procedure has been shown to be effective in several instances, 
including in a recent publication by Houston et al. (2010) where detection of fibrinogen 
degrading enzymes of B. fragilis was demonstrated. In order to be able to match the size 
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of the electrophoresed proteins in the all gels were run without the use of β-
mercaptoethanol.  
 
      A                                                                   B 
         M           ExC                 CFE                       M                ExC                CFE               
 
 
 
 
 
 
 
 
 
Figure 2.2 Collagen Zymography B. fragilis 638R proteins.  (A) Coomassie stained SDS – 
PAGE. (B) Collagen Zymogram. Lanes: (M) PageRuler
TM
 #SM0671; (ExC) 6.5 µg of 
extracellular fraction; (CFE) 75 µg cell free extract.  
 
 
Collagen is a large molecule and cannot be internalized, meaning that any collagenase 
enzymes would have to be either membrane bound or secreted. For this reason the 
concentrated cell supernatant (ExC fraction) and the CFE, containing both the 
cytoplasmic and membrane fractions, were used initially in the zymographic analysis. In 
both these fractions (Figure 2.2. B), a distinct protease activity band was seen at 
approximately 45 kDa. Another two areas of activity were observed in the ExC fraction 
at approximately 73 – 75 kDa and 110 – 120 kDa but these could not be observed as 
discrete bands like the ~45 kDa one. It is important to note that although only 6.5 µg of 
the ExC fraction was loaded on the zymogram, a far more distinct ~45 kDa protease band 
was observed in this fraction, as compared to in the CFE fraction which had 75 µg of 
protein. This indicates that the collagenases make up a larger proportion of the ExC 
fraction.  
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2.3.3 BIOINFORMATIC SEARCH FOR COLLAGENASE CANDIDATES  
 
The genomes of various B. fragilis strains have been sequenced and annotated, including 
that of the B. fragilis 638R strain. Although there were at least three areas of collagen 
degradation observed in the zymograms, the ~45 kDa collagenase band was the only 
descrete band which allowed for relatively accurate estimation of the protein size. For 
this reason, the genome annotation was searched in order to find possible gene candidates 
for the ~45 kDa collagenase. Putative protein sequences corresponding to genes 
annotated as putative protease encoding genes were compared to the predicted protein 
sequences of other known proteases in the NCBI database. These were narrowed down to 
those annotated as putative endopeptidases with predicted protein sizes between 43 and 
55 kDa (Table 2.3).   
 
Table 2.3 Endopeptidases of B. fragilis 638R with a MW range between 43 and 55 kDa 
 
Of the five putative protease gene candidates, BF638R4511, had the highest predicted 
amino acid identity was to the type protease, PrtC, of P. gingivalis. This protease is a 
collagenase of P. gingivalis, known to degrade collagen Type I (Kato et al., 1992; 
Takahashi et al., 1991). A comparison of the genomic context of the prtC gene from P. 
gingivalis and the BF638R4511 gene from B. fragilis 638R revealed that both are found 
in gene clusters, with some of the genes sharing similar putative functions (Figure. 2.3).  
PROTEIN 
NAME 
LOCUS TAG 
BF 638R 
MW 
(kDa) 
MEROPS DESIGNATION % IDENTITY (ID) TO FAMILY/  
SUBFAMILY TYPE PROTEASE 
putative exported 
peptidase 
BF638R0332 49.5 
Metallo-peptidase subfamily 
M23B 
8.49% ID to lysostaphin of Staphylococcus 
simulans  (Thumm and Gotz, 1997) 
putative peptidase BF638R2765 42.5 
Cysteine peptidase family C11 12.64% ID to Clostripain of  Clostridium 
histolyticum  (Dargatz et al., 1993) 
putative protease BF638R3514 51.1 
Metallo-peptidase subfamily 
M50B 
4.82% ID to Stage IV sporulation protein 
FB of Bacillus subtilis (Cutting et al., 1991) 
putative protease BF638R3965 47.9 
Metallo-peptidase subfamily 
M16B 
15.43% ID to Mitochondrial-processing 
peptidase subunit beta of  Saccharomyces 
cerevisiae  (Witte et al., 1988) 
putative peptidase BF638R4511 47.4 
family of peptidases of unknown 
catalytic mechanism U32 
49.41% ID to PrtC of Porphyromonas 
gingivalis W83 (Kato et al., 1992) 
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B. fragilis 638R 
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Figure 2.3 Comparison of the genomic context of the putative B. fragilis 638R collagenase gene, 
clg, to the P. gingivalis W83, prtC collagenase gene. (A) Arrangement of genes in P. gingivalis 
W83 and B. fragilis 638R; (B) Comparison of gene annotation and identity. Predicted protein size 
given in brackets.  
 
The first four genes in the P. gingivalis cluster encode very similar predicted protein sizes 
to the first four genes in the cluster of B. fragilis 638R. The queA gene of P.gingivalis 
and BF638R4513 of B. fragilis, encode proteins with similarities to enzymes involved in 
the processing of tRNA, although they share only about 9 % amino acid identity, as 
determined by the multiple sequence alignment function of DNAMAN. The next gene 
pair shares about 13 % protein sequence identity but BF638R4512 has no similarity to 
any protein of known function.  
P. gingivalis 
W83 ORF 
ANNOTATION B. fragilis 
638R ORF 
ANNOTATION % 
IDENTITY 
PG1540 
(queA) 
Putative S-adenosylmethionine: tRNA 
ribosyl transferase isomerase (40 kDa) 
BF638R4513 Putative TIM-barrel protein, 
dihydrouridine synthase (36 kDa) 
9.18 % 
PG1541 (folk) Putative 2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
pyrophosphokinase (16.8 kDa) 
BF638R4512 Hypothetical protein of unknown 
function    (17  kDa) 
12.74 % 
PG1542 (prtC) Collagenase  (46.5 kDa) BF638R4511 Putative peptidase (47.3 kDa) 67.38 % 
PG1543  Putative thioesterase family protein 
(16 kDa) 
BF638R4510 Putative thioesterase protein     
(15 kDa) 
45.00 % 
PG1544 
(yaaA) 
Hypothetical protein of unknown 
function (29 kDa) 
BF638R4509 Putative DNA processing Smf-
like protein (40.8 kDa) 
8.56 % 
         queA                             folK                              prtC                                    PG1543                                   yaaA 
 BF638R4513                           4512                               4511                                   4510                         4509                                               
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The genes of interest, prtC and BF638R4511, have about 67 % protein sequence identity 
based on the predicted protein sequence from the fully sequenced and annotated genome 
of P. gingivalis W83 available on NCBI. It should be noted that this was a greater 
percentage identity than that seen when BF638R4511 was compared to the protein 
sequence lodged on MEROPS. This is because the MEROPS database reflects the protein 
sequence predicted from the studies done by Kato et al in 1992, before the genome 
sequence was available. In that study, the PrtC was found to be produced from a cloned 
gene isolated from a genomic library of P. gingivalis. The predicted sequence from this 
clone gave a protein of 330 amino acids (AA), as opposed to the 414 AA size predicted in 
the genome sequence. In that study (Kato et al., 1992), the protein observed to have 
collagenase activity was approximately 35 kDa in size, but no protein sequencing was 
ever performed, so the actual size of the gene encoding this enzyme remains unclear. In 
the study reported in this thesis, the high sequence similarity between the two gene 
clusters, including a 45 % protein identity between the genes down stream of prtC and 
BF638R4511 (both putative thioesterases), prompted the continuation of the studies into 
this gene as a putative collagenase candidate in B. fragilis. 
 
 
2.3.4 MUTAGENESIS OF CLG CANDIDATE 
 
Insertional mutagenesis of the putative collagenase gene, BF638R4511 (referred to 
hereafter as clg) was the first step in establishing whether it was responsible for the 
production of the ~45 kDa protease activity band seen on the collagen zymograms. This 
previously described method of targeted gene disruption (Shoemaker et al., 2000) 
involves a homologous recombination event between the chromosomal copy of the target 
gene and an internal fragment of it, carried on a suicide vector (pGERM). This 
recombination event results in the integration of the pGERM vector into the gene, 
causing its disruption (Figure. 2.4 A). Since the pGERM based plasmid (carrying the  
ermG gene) cannot replicate in B. fragilis, only strains where it has integrated into the 
genome will display the ErmR phenotype.  The resulting B. fragilis 638R transconjugants 
are, therefore, selected for by growth on media containing erythromycin.  
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A                                                                                  B 
(i) Wild-type 638 R clg 
 
                                                                                                       
 
                                                                                                                                                                    
 
                                                                                                                                 2.1 kb 
                                                                                                     (ii)  Mutant 638 R clg- 
 
 
 
                                                                                                        1.4 kb                                  1.5 kb 
 
Figure 2.4 Schematic diagram of the targeted gene disruption. (A) Illustration of the principle of 
gene disruption by homologous recombination. The recombinant event occurs between the 
cloned, internal fragment of the target gene (white box on pGERM with insert, pGERMint) and 
the chromosomal copy of the gene (blue). The internal fragment is therefore duplicated on each 
side of the inserted pGERM. The black area represents the pGERM plasmid DNA and the primer 
binding sites are shown. (B) Expected PCR products of (i) Wild-type B. fragilis 638R clg and (ii) 
B. fragilis 638R clg
-
 mutant.  
 
 
Confirmation of insertion into the gene of interest is done by PCR using M13 primers, 
which bind to the pGERM plasmid sequence only, and primers for the full length gene, in 
this case ClgF and ClgR. The wild-type strain should only produce a product with 
primers ClgF and ClgR and the mutant strain only with the appropriate combination of 
full length and M13 primers (Figure. 2.4 B). 
 
In this study, the predicted 2.1 kb PCR product was produced with the wild-type            
B. fragilis 638R DNA (Figure. 2.5, lane 3) and not with the clg- mutant DNA (lane 2). 
Similarly PCR using primers M13R with ClgR, and M13F with ClgF, only gave products 
with the mutant (lanes 4 and 6) and not the wild-type DNA (lanes 5 and 7). Sequencing 
ClgR 
ClgF 
ClgF 
ClgR 
M13R 
M13F 
PCR PCR
BA
 A
B D
 C
pGERMint
W X 
X Z 
W Y 
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of the mutant PCR products (Figure. 2.5., lanes 4 and 6) with primers M13R and M13F 
confirmed the junction between the pGERM inserted vector and the interrupted clg gene.  
 
 
                         M         1           2          3                                                                  M         4          5           6          7    
     
 
 
 
 
 
 
 
 
 
 
Figure 2.5 PCR of DNA from wild-type B. fragilis 638R and B. fragilis 638R clg- mutant for 
confirmation of insertion. Lanes: (M) molecular weight marker of λ-phage DNA digested with 
PstI; Primers ClgR and ClgF with (1) no DNA template, (2) mutant DNA, (3) wild-type DNA; 
Primers ClgR and M13R with (4) mutant DNA, (5) wild-type DNA; Primers ClgF and M13F 
with (6) mutant DNA, (7) wild-type DNA. 
 
 
 
2.3.5 COLLAGEN PROTEASE PROFILE OF MUTANT AND WILD-TYPE  
 
In order to detect any changes in the collagen degradation profile of B. fragilis 638R 
caused by the interruption of the clg gene, collagen zymography was performed. The 
CFE and ExC fractions of the B. fragilis 638R clg- mutant were compared to those of the 
wild-type strain (Figure. 2.6).  
 
 
 
2.84 kb 
 
2.14 kb 
 
1.70 kb 
 
 1.16 kb 
1.5 kb 
1.4 kb 
2.84 kb 
 
2.14 kb 
 
1.70 kb 
 
 1.16 kb 
2.1 kb 
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Figure 2.6 Collagen zymogram comparison of B. fragilis 638R wild-type (WT) and B. fragilis 
638R clg
-
 mutant (MUT). (A) Cell free extracts (75 µg protein), (B) Extracellular fractions (6.25 
µg protein). M: PageRuler
TM
 #SM0671  
 
 
No changes in the collagenolytic profiles of B. fragilis 638R were observed when the 
putative collagenase gene, clg, was interrupted. Both the wild-type (WT) and clg- mutant 
(MUT) produced zones of collagen hydrolysis at about 112 – 120 kDa and 45 kDa. This 
result indicates that the BF638R4511 ORF does not produce the collagenase of ~45 kDa 
described in this study, under the growth and assay conditions used.  
 
 
2.4 CONCLUSION 
 
As a starting point to this thesis we looked to test whether B. fragilis could after all 
degrade collagen. The approach taken was one not previously used in testing for the 
ability of B. fragilis to degrade this substrate. By the use of zymographic techniques, it 
was possible to demonstrate for the first time that B. fragilis has the ability to produce a 
specific group of collagen degrading enzymes. At least two reproducible zones of 
collagen degradation were observed using collagen Type I zymography.  These were of 
about 110 to 120 kDa, and of 45 kDa. An area of degradation at about 73 to 75 kDa was 
also seen but its presence was not easily reproducible. Although there have been reports 
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of proteaseses of  100 kDa (Chen et al., 1995), 73 kDa (Gibson and Macfarlane, 1988a), 
and 45 kDa (Houston et al., 2010) in B. fragilis, none of the genes encoding for these 
enzymes have been found. In future studies, each of these collagenases should be 
investigated in detail, but in this dissertation only the distinct ~45 kDa collagenase band, 
found both extracellularly and in the cell free extracts, was analysed further.  
 
Bioinformatic analysis of the annotated genome of B. fragilis appeared to be the simplest 
approach to find the putative protease gene candidates for the collagenase of ~45 kDa but 
it did not prove fruitful here. The putative B. fragilis 638R gene homologue, of the prtC 
collagenase gene of P. gingivalis, which appeared to be a strong candidate, was shown 
not to be responsible for the production of the 45 kDa collagenase of interest. This 
genomic approach may have been too narrow and overly dependent on the detection of 
conserved protease domains and homology with other published protease enzymes. 
Numerous genes are annotated as hypothetical proteins, representing a reservoir of 
putative proteins whose function was not easily assigned during the annotation process.   
 
With this in mind it became clear that the next step in trying to identify the genes 
encoding the proteases observed in this study was by the isolation and purification of the 
proteases followed by protein sequencing (mass spectrometry). The one dimensional 
separation of the protein fractions in this chapter showed that a large number of proteins 
were present, making it impossible to assign the protease activity to a particular protein 
band. An alternative approach would be to use active cellular fractions with fewer 
proteins and to separate these by 2-dimensional gel electrophoresis (2D SDS-PAGE). The 
ExC fraction would have been a good option for this purpose but it required the 
concentration of unmanageable volumes of extracellular supernatant. As an alternative, 
further fractionation of the CFE, which also contained the predominant ~45 kDa protease, 
was to be attempted. This fraction represents the whole cell lysate, including the 
cytoplasmic, inner and outer membranes.  
 
As previously discussed, both proteases and molecules that facilitate bacterial adhesion to 
host ECM components have been described as putative virulence factors. MSCRAMMs 
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or cell surface adhesins are usually isolated from the outer membrane protein fraction 
(OMP). The next chapter describes the broadening of the study to include the 
identification of collagen type I adhesins. The use of the OMP fraction, therefore, would 
be ideal for a comparison of the collagen binding and degrading proteins present in B. 
fragilis with a view to identifying any collagenases with collagen binding domains.  
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3.1 INTRODUCTION  
 
The ability of a B. fragilis 638R laboratory strain to degrade an important ECM protein, 
collagen type I, was investigated as described in Chapter 2. Although quantitative assays 
for collagenase activity were not successful due to various technical difficulties, two 
distinct collagenase bands were identified qualitatively using zymography. This showed 
that B. fragilis 638R could, in fact, degrade this form of collagen.  
 
As discussed in Chapter 1, the ability of bacteria to bind, as well as to degrade, 
components of the ECM is believed to be important for virulence, with attachment being 
considered the first step in colonization by both commensal and pathogenic bacteria 
(Pumbwe et al., 2007). The ability of various Bacteroides spp. to bind collagen type I has 
been previously examined (Szoke et al., 1997). It was shown that more B. fragilis strains 
bound to collagen as compared to other Bacteroides spp. although only about 70 % of the           
B. fragilis isolates tested could bind the substrate. It was, therefore, important to 
determine how effectively the B. fragilis 638R lab strain was able to bind collagen as 
compared to other recently isolated B. fragilis clinical strains.  
 
Assessment of collagen binding properties in bacteria has previously been done using the 
particle agglutination assay (PAA) which involves mixing bacterial suspensions with 
collagen coated latex beads (Naidu et al., 1988). Adhesion of the bacteria to collagen 
causes the beads to agglutinate, with the level of agglutination being proportional to the 
degree of binding.  
 
The ability of B. fragilis to bind collagen could also offer a method of purifying the 
collagenases, since various collagenases have been shown to have collagen binding 
domains (Chen and Duncan, 2004; Itoi et al., 2006; Watanabe, 2004). If any of the          
B. fragilis collagenases observed in Chapter 2 have such substrate binding domains, then 
collagen affinity chromatography could be used to purify these enzymes.  
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Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) is another method that 
may be used to separate proteins for subsequent mass spectroscopy identification. There 
have been reports of this technique being used in combination with zymography to 
identify proteases (Pucci-Minafra et al., 2001). There are, however, limitations to this 
technique as certain proteases do not remain active, or cannnot be reactivated after 
exposure to the denaturing process involved in 2D-PAGE. Similarly, 2D-PAGE has been 
used to identify bacterial ECM adhesins in combination with Far Western analysis (Yu et 
al., 2006). Collagen Far western analysis has not been reported for B. fragilis and is 
potentially a good method of correlating the collagenase bands seen in the collagen 
zymograms to possible collagen adhesin proteins.  
 
This chapter, therefore, describes the evaluation of clinical isolates of B. fragilis for their 
ability to bind to and degrade collagen, and the selection of the best candidate strain for 
further studies. The use of various new techniques for the isolation of putative collagen 
adhesins and proteases is also detailed.  
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3.2 MATERIALS AND METHODS  
 
3.2.1 BACTERIAL STRAINS AND GROWTH CONDITIONS 
 
Twenty-four clinical isolates, preliminarily identified as B. fragilis, were sourced from 
the Groote Schuur Service Laboratory at the Groote Schuur Hospital in Cape Town, 
Western Cape, South Africa (Table 3.1). Additional reference strains are shown in Table 
3.2.  
 
 
Table 3.1 Bacterial Strains from Groote Schuur Hospital (GSH) 
Strain Name Clinical Identification Number Site of Isolation 
GSH 2   1675193 Intra abdominal 
GSH 3   205615 Septic wound-neuro surgery 
GSH 5   525057 Retrocaecal – appendicitis 
GSH 6   451653 Pus swab – thigh 
GSH 7   73849 Peritoneal fld 
GSH 8   521205 Pus swab – intra abdominal 
GSH 9   222263 Information not available 
GSH 10   379509 Information not available 
GSH 12   21152 (24/02/03) Bile 
GSH 13   96360 Pus swab – hip abscess  
GSH 14   181360 (5/07/03) Hip abscess 
GSH 15   0031574 Pus swab – urology/plastic surgery 
GSH 16   263921 Pus swab – site unknown 
GSH 17   64699 Pus swab – site unknown 
GSH 18   76217 (11/04/03) Pus swab – nephrectomy 
GSH 19   64455 Blood culture 
GSH 20   48078 Pus swab – hip 
GSH 21   645186 Hip aspirate 
GSH 22   321276 Pus swab – urology/plastic surgery 
GSH 23   1098582 Pus swab abdominal 
GSH 24   1437797 Brain abscess 
GSH 25   3256692 Pus swab endocrine gynaecology 
GSH 28  1237733  Peri-anal abscess  
GSH 30  1651096  Pus swab empyema (lung) 
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Table 3.2 Other bacterial strains used 
Strain Genotype/phenotype Reference 
Staphylococcus aureus  University of Cape Town 
Micrococcus luteus  University of Cape Town 
B. fragilis 638R Clinical strain, Rif
R
 Gent
R
 (Privitera et al., 1979) 
B. fragilis MC2 Known laminin binder (Ferreira et al., 2006) 
B. fragilis P35 Known collagen binder (Soki et al., 1999) 
RifR GentR denotes resistance to rifampicin and gentamycin. 
 
All Bacteroides strains were grown on BHIS agar and broth without antibiotic, as 
described in Chapter 2. Staphylococcus aureus and Micrococcus luteus were grown on 
nutrient agar (NA) (Merck) and Luria-Bertani (LB) broth, aerobically, at 37 and 30°C 
respectively. 
 
 
3.2.2 16S rRNA AND RECA GENE SEQUENCING FOR IDENTIFICATION OF 
GROOTE SCHUUR CLINICAL ISOLATES 
 
All PCR reactions were performed as describe in Chapter 2. Isolates GSH 5, 13, 18, and 
19 were identified by sequencing of the recA gene using primers RIF (5′-CAG GTT CGA 
TAG CAC TGA ATG C-3′) and RRA (5′-GGG CAT GCC TAT CGA GTT GG-3′) 
(Steffens et al., 2010). The remainder of the GSH isolates were identified by sequencing 
of the 16S rRNA gene which was amplified using universal primers F27 (5‟-
AGAGTTTGATCITGGCTCAG-3‟) and R5 (5‟-ACGGITACCTTGTTACGACTT-3‟) 
(Cheneby et al., 2000).  
 
DNA sequencing was performed by Macrogen Inc., Seoul, Korea. The sequences 
obtained were analysed using BLAST 2.2.17 (Altschul et al., 1997; Schaffer et al., 2001).  
 
 
3.2.3 PARTICLE AGGLUTINATION ASSAYS (PAA) 
 
The particle agglutination assays were performed as previously described (Naidu et al., 
1988) with amendments as described below.  
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3.2.3.1 LATEX BEAD PREPARATION 
 
One millilitre of 0.8 µm (diameter) latex beads (Sigma-Aldrich, LB8) was mixed with     
3 ml of 0.2 M glycine buffer. The mixture was centrifuged at 3 000 rpm (735 g) in an 
Eppendorf 5415C bench top centrifuge or 30 min, the supernatant was discarded, and the 
pellet was washed twice with glycine buffer. Finally, the pellet was resuspended in 
glycine buffer with collagen Type I from calf skin (elastin products company inc.) to a 
final substrate concentration of 5 mg/ml. The tube was then incubated at 30 °C, and 
shaken horizontally for approximately 19 h. After centrifugation at 3 000 rpm (735 g) in 
an Eppendorf 5415C bench top centrifuge or 30 min, the supernatant was discarded and 
the pellet washed twice with glycine buffer. Finally the pellet was resuspended in 1.5 ml 
glycine buffer with 0.01 % (w/v) bovine serum albumin (BSA, Fermentas #B14). The 
tube was shaken for 18 h at 4 °C until the beads were completely resuspended. A control 
of non-coated beads, in only glycine buffer with 0.01 % (w/v) BSA (no collagen), was 
also prepared in this way. 
 
 
3.2.3.2 BACTERIAL PREPARATION AND PAA 
 
Bacterial colonies were resuspended in phosphate buffered saline (PBS) (pH7.4) and 
adjusted to 4 McFarland standard (or OD600nm at 0.669). On a microscope slide, 10 µl of 
beads and 10 µl of bacterial preparation were evenly mixed and shaken gently for 
approximately 3 minutes. The controls were: PBS mixed with coated and non-coated 
beads, in order to determine the effect of PBS on agglutination, and bacteria mixed with 
non-coated beads to determine if there was any substrate independent agglutination. S. 
aureus was used as a positive control for the binding of collagen and assigned a score of 
strong binding (3), whereas M. luteus was used as a negative control and assigned a score 
of no binding (1) based on their ability to cause bead agglutination. All experimental 
strains were scored based on a comparison with the controls. 
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3.2.4 PROTEIN SAMPLE PREPARATION      
 
 
3.2.4.1  CELL FREE EXTRACTS (CFES) 
 
B. fragilis strains were grown anaerobically for 16 h to late log/early stationary phase in 
BHIS broth. The cells were harvested by centrifugation in a Beckman JA-14 rotor (10 
000 rpm or 9600 g, 4°C, 15 min each) and cell pellets washed twice in 1X PBS pH 7.4 by 
centrifugationin a Beckman JA-14 rotor (10 000 rpm or 9600 g, 4°C, 5 min each). The 
pellets were then resuspended in 1 ml PBS and the cells were disrupted by sonication 
using a Misonic sonicator 3000 at a power output of 3 W for 5 rounds of 30 s. Cell debris 
was removed by centrifugation in an Eppendorf 5415C bench top centrifuge (14 000 rpm 
or 16 000 g, 4°C, 10 min). The supernatant was collected (CFE) and protein 
concentrations were determined using Bio-Rad Protein Assay Dye Reagent Concentrate 
according to the manufacturer's instructions (Bio-Rad Laboratories, cat # 1500 - 0006). 
 
 
3.2.4.2  OUTER MEMBRANE PROTEIN FRACTION (OMP) 
 
The outer membrane protein extraction protocol was based on a previously described 
method (Ferreira et al., 2008) with various modifications described here in detail. For the 
preparation of the OMP fraction, the B. fragilis CFE was ultracentifuged for 1 h at 39 000 
rpm (100 000 g) in a Beckman 50Ti rotor. The resulting crude membrane pellet was 
resuspended in 200 µl of PBS (pH7.4) and mixed with up to 9.8 ml of 0.3 % (w/v) N-
Lauroylsarcosine sodium (Sigma, L5125) solution for 1 h at 4 °C to dissolve the inner 
membrane. The outer membrane was then collected by ultracentrifugation as described 
above, and the pellets were washed using PBS (pH 7.4). After a final ultracentrifugation 
step, the OMP pellet was resuspended by vigorous agitation in 500 µl PBS (pH7.4). 
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3.2.5 COLLAGEN FAR WESTERN ANALYSIS 
 
The Far Western procedure was adapted from previously described methods (Esmay et 
al., 2003; Ferreira et al., 2006) and is briefly described here. The protein sample (75 µg) 
was mixed in a 1:1 ratio with 2X SDS gel loading buffer (without β-mercaptoethanol) 
(0.125 M Tris-HCl [pH6.8], 4 % SDS, 20 % glycerol, 0.002 % bromophenol blue) and 
incubated at room temperature for 10 min prior to electrophoresis in a 10 % SDS (w/v) 
polyacrylamide gel without β-mercaptoethanol (Laemmli, 1970). PageRulerTM Prestained 
Protein Ladder (Fermentas, #SM0671) was used as the molecular weight standard for all 
protein gels. Samples were run on two separate duplicate gels. One set of separated 
protein was stained with Coomassie brilliant blue, and the other was transferred on to a 
nitrocellulose membrane using the Trans-Blot® SD DNA/RNA Blotting Kit from Bio-
Rad as per the manufacturer‟s instructions.  
 
The nitrocellulose blots were blocked overnight by incubating at room temperature (RT) 
in blocking buffer (1X PBS buffer, pH7.2 with 1.5 % BSA [Roche, 10 735 086 001] and 
5% skim milk). This was followed by a 3 h incubation period at RT in PBS-B-T buffer 
(1X PBS, pH7.2; 1.5 % BSA; 0.1 % Tween) containing 20 µg/ml of collagen Type I from 
calf skin (Elastin Products Company Inc.). The membrane was then washed three times 
with PBS-B-T buffer, and incubated with anti-collagen type I (Rabbit) antibody 
(Rockland, 600-401-103-0.1) at a 1:500 dilution, for 1 h, followed by another 3 washes. 
Incubation with peroxidase conjugated anti-rabbit IgG (Goat) antibody (1:5000 using 
Rockland, 611-1302; or 1:2500 using Gene Tex, GTX77060) was then performed for 1 
hour at RT, followed by 3 washes with PBS-T buffer (1 X PBS, pH7.2; 0.1 % Tween) 
and the membrane was finally developed with TMB Membrane Peroxidase substrate 
(KPL, 50-77-18). In order to confirm the specificity of the anti-collagen type I (Rabbit) 
antibody a control blot was exposed to the antibody without the collagen binding step. 
 
 
3.2.6 COLLAGEN ZYMOGRAPHY 
 
Collagen zymography was performed as described in Chapter 2.  
64 
 
3.2.7 COLLAGEN AFFINITY CHROMATOGRAPHY  
 
3.2.7.1  COUPLING OF COLLAGEN TO CYANOGEN BROMIDE-    
                        ACTIVATED SEPHAROSE 
 
Cyanogen bromide (CnBr) activated sepharose matrix (Sigma, C9142) was coupled with 
collagen Type I by the method described below which was adapted from the 
manufacturer‟s instructions.  
 
CnBr-activated resin (1 g) was rehydrated for 30 min in cold 1 mM HCl and washed 
several times in approximately 10 ml volumes of 1 mM HCl to a total volume of 200 ml. 
The resin was then washed with 5 to 10 volumes of sterile distilled water (dH20) followed 
by a wash with coupling buffer (0.1 M NaHCO3, 0.5 M NaCl, pH8.5). This buffer was 
replaced by coupling buffer containing 5 mg/ml of collagen type I, and the suspension 
was mixed, using an end-over-end stirrer, at 4 °C for 16 to 19 h for coupling to take 
place. The unreacted collagen was removed by washing 3 times with coupling buffer. 
Coupling buffer was then replaced by 0.2 M glycine buffer (pH8) and the resin was 
incubated in this for 2 h at room temperature (about 18 to 25 °C). The resin was then 
washed alternately with the alkaline, coupling buffer, and acidic acetate buffer (0.1 M 
sodium acetate, 0.5 M NaCl, pH 4) for four cycles. The buffer was then replaced with 1M 
NaCl and the column was packed and stored in 1 M NaCl with 0.1% (w/v) sodium azide 
at 4°C until use. 
 
 
3.2.7.2  AFFINITY PURIFICATION OF COLLAGEN ADHESINS 
 
The outer membrane protein (OMP) fraction or cell free extract (CFE) of B. fragilis 
GSH18 strain (3-7 µg in 10 ml PBS) were passed three times through the collagen 
affinity column which was then washed with 20 ml PBS. The first seven column volumes 
(2 ml) were collected (W1 to W7). Elution of the bound proteins was done in a step-wise 
manner with 2 ml of 0.15, 0.3, 0.6, 1, 1.5, and 2 M NaCl solution.  
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The protein content of 200 µl of the OMP (or CFE) samples, the non-binding fraction 
(NBF) and wash fractions (W1 to W7), and 2 ml of each elution fraction were 
precipitated using 100 % (w/v) Trichloroacetic acid (TCA) (Isaacson et al., 2006). Each 
protein pellet was then resuspended in 20 µl of 1X SDS-PAGE loading dye and 
examined on SDS – 10 % (w/v) polyacrylamide without β-mercaptoethanol.   
 
 
3.2.8 TWO-DIMENSIONAL (2D) GEL ELECTROPHORESIS 
 
Outer membrane proteins (250 µg per strip) were precipitated using a trichloroacetic acid 
(TCA) precipitation protocol based on a previously described method (Isaacson et al., 
2006). Briefly, samples were mixed with 100% (w/v) TCA at a volume ratio of 4:1 
(sample to TCA), placed on ice for 20 min, and the precipitated proteins collected by 
centrifugation in an Eppendorf 5415C bench top centrifuge (14 000 rpm or 16 000 g, 
4°C, 5 min). The pellets were then washed three times with ice-cold 80%  (v/v) acetone 
and dried using a Savant Speed Vac® Plus SC210A (Thermo Quest). Pellets were then 
solubilised in 100 µl of urea lysis buffer (ULB) (8 M urea, 2% Triton X-100, 2% 
CHAPS, 2 M thiourea) with 2 µl of 1 M NaOH. Once completely solubilised, 2.5 µl of 
50% (w/v) dithiothreitol (DTT) with bromophenol blue, 7.5 µl of 20% ampholytes (pH 3-
10) (Bio-Lyte 3-10, Bio-Rad) and 15 µl of ULB were added to the mixture which was 
then applied to a 7 cm pH 3 – 10 IPG strip (Bio-Rad) for passive rehydration. Iso-electric 
focusing (IEF) was performed in a Protean IEF Cell (Bio-Rad) as follows: 250V, 15 m; 
2500V, 2h30m; 4000V, 20 000Vh. Equilibration of focused strips before second 
dimension separation was done sequentially in equilibration buffer I (6 M urea, 30% (v/v) 
glycerol, 2% (w/v) SDS, 1% (w/v) DTT, bromophenol blue) and equilibration buffer II (6 
M urea, 30% (v/v) glycerol, 2 % (w/v) SDS, 4.8% (w/v) iodoacetamide, bromophenol 
blue). The second dimension was done on a 10% SDS polyacrylamide gel.  
 
Four gels were run for the wild-type B. fragilis GSH18 strain for analysis and protein 
spot picking. Another gel was run for Far Western analysis, which was performed as 
described in 3.2.5.  
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3.3 RESULTS AND DISCUSSION  
 
3.3.1 IDENTIFICATION OF STRAINS 
 
The 16S rRNA genes of the strains were sequenced in order to confirm the identity of the 
24 clinical isolates from Groote Schuur hospital as B. fragilis. Additional, sequencing of 
the recA gene of strains GSH 5, 13, 18, and 19 was done for definitive identification of 
these isolates. The sequencing results, presented in Table 3.3 show that all except one of 
the strains were, in fact, B. fragilis. Strain GSH 24 was, however, identified as 
Bacteroides thetaiotaomicron and was, therefore, not used further in this study.  
 
Table 3.3. Identification of clinical isolate from Groote Schuur Hospital 
Strain Accession  Description Max. Identity 
GSH 2 X83940.1 B.fragilis 12491, 16S rRNA  99% 
GSH 3 X83940.1 B.fragilis 12491, 16S rRNA  99% 
GSH 5 AP006841.1 B. fragilis YCH46, putative RecA  99% 
GSH 6 AP006841.1 B. fragilis 638R, 16S rRNA 99% 
GSH 7 X83942.1 B.fragilis B119, 16S rRNA  99% 
GSH 8 X83938.1 B.fragilis 2991, 16S rRNA  99% 
GSH 9 X83941.1 B.fragilis TAL3636, 16S rRNA  99% 
GSH 10 AB542764.1 B. fragilis JCM 11017, 16S r RNA  99% 
GSH 12 AP006841.1 B. fragilis 638R, 16S rRNA 99% 
GSH 13 AP006841.1 B. fragilis YCH46, putative RecA 99% 
GSH 14 X83938.1 B.fragilis 2991, 16S rRNA  99% 
GSH 15 X83943.1 B.fragilis Bfr81, 16S rRNA  99% 
GSH 16 AP006841.1 B. fragilis 638R, 16S rRNA 99% 
GSH 17 AP006841.1 B. fragilis 638R, 16S rRNA 100% 
GSH 18 AP006841.1 B. fragilis YCH46, putative RecA 99% 
GSH 19 M63029.1 B. fragilis YCH46, putative RecA 99% 
GSH 20 AP006841.1 B. fragilis 638R, 16S rRNA 100% 
GSH 21 EU728706.1 B. fragilis 638R, 16S rRNA 99% 
GSH 22 AB510701.1 B.fragilis JCM 11019, 16S rRNA  99% 
GSH 23 AP006841.1 B. fragilis 638R, 16S rRNA 99% 
GSH 24 AB510710.1 B. thetaiotaomicron JCM 5827, 16S rRNA 99% 
GSH 25 AP006841.1 B. fragilis 638R, 16S rRNA 99% 
GSH 28 AB542764.1 B. fragilis JCM 11017, 16S rRNA  99% 
GSH 30 AB510701.1 B.fragilis JCM 11019, 16S rRNA  99% 
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3.3.2 PARTICLE AGGLUTINATION ASSAYS 
 
The 23 B. fragilis clinical isolates were first analyzed for their ability to bind to collagen 
using the particle agglutination method. S. aureus and M. luteus were used as positive 
and negative controls respectively, as recommended by Naidu et al. (1988). In addition to 
these controls, a known collagen binding strain, B. fragilis P35 (Soki et al., 1999) and a 
known laminin binder, B. fragilis MC2 (Ferreira et al., 2006) were tested for comparison 
with the South African clinical isolates. B. fragilis 638R was also tested to evaluate the 
hypothesis that recent clinical isolates may be more virulent and, therefore, display 
greater ability to bind and degrade the ECM protein, collagen.  
 
All, except two of the experimental strains tested (GSH 12 & 25), could bind collagen 
type I, although none were strong collagen binders (Table 3.4 and Figure. 3.1). The 
control strains B. fragilis 638R and MC2 were both weak collagen binders (binding level 
1) as were the majority of the clinical isolates (16/23). As expected B. fragilis P35 was a 
good collagen binder (binding level 2), as were isolates GSH 5, 7, 13, 18 and 19. These 
GSH isolates were further characterized by collagen far western and collagen 
zymography and compared to the three control strains.  
  
       Table 3.4: Particle agglutination assays (PAA) of B. fragilis strains 
 
 
 
 
 
 
 
 
 
 
 
*No binding (0), weak binding (1), good binding (2) and strong binding (3). 
Strain Degree of Binding
*
 Strain Degree of Binding
*
 
638R 1 GSH 14 1 
P35 2 GSH 15 1 
MC2 1 GSH 16 1 
GSH 2 1 GSH 17 1 
GSH 3 1 GSH 18 2 
GSH 5 2 GSH 19 2 
GSH 6 1 GSH 20 1 
GSH 7 2 GSH 21 1 
GSH 8 1 GSH 22 1 
GSH 9 1 GSH 23 1 
GSH 10 1 GSH 25 0 
GSH 12 0 GSH 28 1 
GSH 13 2 GSH 30 1 
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Figure 3.1. Particle agglutination assays. (A) Agglutination scoring system using controls. No 
binding (0) was represented using M. luteus, weak binding (1) using B. fragilis MC2, good 
binding (2) using B. fragilis P35, and strong binding (3) using the S. aureus. (B) Distribution of 
binding ability of B. fragilis clinical isolates (GSH strains) to collagen type I.  
 
            
3.3.3  COLLAGEN ADHESINS AND PROTEASES OF CLINICAL STRAINS 
 
In Chapter 2 it was shown that B. fragilis 638R produced a number of collagen proteases 
in different cell fractions. However, in this chapter, five additional clinical strains were 
identified using the PAA method, which could bind collagen better than B. fragilis 638R, 
and these were taken forward for further studies. The collagen protease and adhesion 
profiles of these GSH strains were examined by collagen zymography and collagen Far 
Western analysis.  
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The examination of the CFEs of the five B. fragilis GSH strains, and the control strains, 
B. fragilis 638R, MC2 and P35, revealed that they all produced a protease of about        
45 kDa (refer to Figure. 3.2 for representative gel). A less intense protease band, of about 
37 to 40 kDa, was also observed (Figure. 3.2 B). Similarly, a collagen adhesin band of 
approximately 45 kDa was found in all strains (Figure. 3.2 C). This binding was specific 
as the control blot, in which no collagen binding step was performed, appeared complety 
blank (data not shown). One of the five best collagen binders, GSH18, was chosen for 
further analysis.  
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Collagen Far Western and zymogram of cell free extracts (CFE) and outer membrane 
protein (OMP) of B. fragilis GSH18. (A) Coomassie stained gel, (B) Zymogram, (C) Far 
Western. M: PageRuler
TM
 #SM0671  
 
 
Interestingly, the OMP fraction was not enriched for the adhesin of ~45 kDa, but did 
reveal the presence of two other collagen adhesins at about 32 and 34 kDa (Figure.3.2 C). 
The absence of this ~45 kDa adhesin in the OMP implied that it is present either in the 
cytoplasmic or the inner membrane fraction. The 45 kDa protease band was, however, 
active in both the fractions, as was the smaller 37 kDa band.  
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For a bacterium to be able to bind extracellular components, like collagen, for the 
purposes of attachment, it is necessary that they should express the relevant adhesins on 
their cell surface. In fact, many of the ECM adhesins described for B. fragilis to date have 
all been found in the outer membranes (Ferreira et al., 2009; Pauer et al., 2009). The 
presence of an adhesin and protease band of apparently similar size in the initial CFE Far 
Western and zymogram was interesting since it suggested that the same protein might be 
responsible for binding and degrading the collagen. However, the lack of a detectable 
~45 kDa collagen binding band in the OMP fraction was somewhat disappointing as it 
indicated that the phenotypes might not be attributed to the same protein after all.  
 
However, another scenario is also possible. The putative collagen-binding adhesin could 
be present in the OMP at concentrations that were too low for a detectable Far Western 
band to be seen. The adhesion to collagen is detected as a “snap shot” moment where a 
limited number of collagen molecules bind to the limited number of adhesin molecules 
immobilised on the nitrocellulose membrane. The hydrolytic action of the protease 
component, however, is seen as the cumulative degradation of several collagen molecules 
over the 48 h activation period meaning that even a limited amount of enzyme could 
account for the zone of clearing observed in the zymogram. With this possibility in mind, 
affinity purification was performed using both the CFE and the OMP fractions.  
 
  
3.3.4 AFFINITY PURIFICATION OF COLLAGEN ADHESINS 
 
The affinity purification method was found to be effective in isolating the collagen 
adhesins in the CFE and OMP (Figure. 3.3 and 3.4).  
 
 
 
 
 
 
71 
 
A 
           M       1       2         3        4       5        6        7        8        9           10      11       12      13       14      15 
 
 
 
 
 
B 
          M       1        2         3         4        5        6         7        8        9        10       11       12       13      14      15  
 
 
 
 
 
Figure 3.3 Affinity purification of collagen adhesins of the cell free extract (CFE) of  B. fragilis 
GSH18: (A) Coomassie stained gel, (B) Far Western. Lanes: M: PageRuler
TM
 #SM0671, 1: CFE, 
2: Non-binding fraction (NBF), 3 – 9: Washes 1 to 7 (W1 to W7), 10 -15: Elutions with 0.15, 0.3, 
0.6, 1, 1.5 and 2 M NaCl respectively.  
 
 
The purification process eliminated a large number of proteins, allowing for the 
visualization of a distinct 45 kDa band. This protein band was excised from lane 10    
(0.15 M NaCl). A slightly smaller 44 kDa band just below the above-mentioned band 
became more predominant from lane 13 (1 M NaCl), as the 45 kDa band concentration 
decreased. This was clearly seen in the Far Western as well (Figure. 3.3 B) and for this 
reason both the top (45 kDa) band, in lane 10, and the bottom (44 kDa) band, from lane 
13, were excised and subjected to LC MS/MS analysis. 
 
The purification of the adhesins from the OMP fraction gave interesting results. Collagen 
adhesins were seen from the first elution fraction (Figure. 3.4 B). Only a 32 kDa protein 
band appeared in the Coomassie stained gel (Figure. 3.4 A), which seemed to be eluted 
predominantly at 1M NaCl, and no distinct 34 kDa band was present. The Far western 
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did not reflect an increase in intensity of the 32 kDa band at 1 M NaCl and, surprisingly, 
it was the 34 kDa adhesin band that was more distinct throughout the elution fraction 
(Figure. 3.4 B). A novel 26 kDa band, with corresponding collagen binding activity, was 
eluted at about 2M NaCl. Both the 32 kDa band eluted at 1 M NaCl and the 26 kDa band 
eluted at 2 M NaCl were excised from the protein gel and subjected to LC MS/MS 
analysis. 
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Figure 3.4 Affinity purification of collagen adhesins of the outer membrane protein fraction 
(OMP) of B. fragilis GSH18: (A) Coomassie stained gel, (B) Far Western. Lanes: M: 
PageRuler
TM
 #SM0671, 1: CFE, 2: Non-binding fraction (NBF), 3 – 9: Washes 1 to 7 (W1 to 
W7), 10 -13: Elutions with 0.6, 1, 1.5 and 2 M respectively.  
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In each purification profile (Figure. 3.2 and 3.3) the adhesin bands could be seen in the 
CFE (or OMP), as well as in the non-binding (NBF) and in the washes, suggesting that 
there was a limit to the amount of adhesins that could bind to this column. The problem 
of scaling up this experiment was, therefore, a limiting factor in the success of the 
purification of the adhesins. In order to be able to visualize the proteins on a Coomassie 
stained SDS-PAGE, the fractions had to be TCA precipitated. This meant that there was 
insufficient purified product for proper zymographic analysis of the protease activity, as  
the concentrated samples lost proteolytic activity in the TCA treatment. Confirmation of 
the collagen adhesive properties of the purified proteins by Far Western analysis was, 
however, unaffected by the TCA treatment.  
 
It is interesting to note that the collagen binding ability, of the putative collagen adhesins 
observed here, is not dependant on the proteins‟ structural conformation. The proteins 
undergo at times both the denaturing affects of SDS treatment and of TCA exposure and 
still retain their collagen binding ability without the need for a renaturing step. This 
phenomenon is observed for other adhesins including the B. fragilis fibrinogen binding 
protein (BF-FBP) (Houston et al., 2010). This property is useful for detection of adhesins 
which have been separated under highly denaturing conditions such as those used in 2-
dimesional gel electrophoresis.  
 
 
3.3.5 TWO-DIMENSIONAL SEPERATION OF COLLAGEN ADHESINS 
 
Two-dimensional gel electrophoresis is a very powerful separation tool. It has been 
previously used, in combination with Far Western hybridization, for detection of 
MSCRAMMs (Microbial Surface Components Recognizing Adhesive Matrix Molecules)  
such as fibronectin adhesins (Yu et al., 2006). To our knowledge this technique has not 
been used previously for the detection of collagen adhesins.  
 
Only the OMP fraction was analysed using 2-dimensional gel electrophoresis. Since this 
fraction contained a smaller number of proteins, the individual protein spots would be 
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seen more distinctly and, therefore, enable them to be excised more accurately for further 
analysis. In order to observe the full spectrum of possible OMP adhesins, a pI range of 3 
to 10 was used. Figure 3.5A shows an example of one of the 2D gels. The various 
Coomassie stained gels were analyzed, using the PDQuest Software version 7.4.0 (Bio-
Rad), in order to match particular protein spots across the various gels. Matching the 
spots seen on the corresponding Far Western blot (Figure 3.5 B), however, was done 
manually due to the lack of coordinating proteins spots on the blot, which are necessary 
for PD Quest analysis. The specificity control, in which the collagen binding step was not 
performed, demonstrated that the adhesin spots seen in the experimental blots were not 
present and therefore the collagen binding is specific (data not shown).  
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Figure 3.5. Identificat ion of collagen-binding proteins from the OMP of B. fragilis GSH18 by two-dimensional gel electrophoresis. OMPs were separated in the 
first dimension on precast IPG strips (pH 3–10, indicated by the arrow above the figures ) followed by separation in the second dimension on 10% SDS-PAGE 
gels. (A) Coomassie stained gels, (B) Collagen Far Western of proteins from 2D-gels. (i) Full gel images; (ii) Enlargement of the areas of interest encased in red. 
Black circles and boxes indicate the position of the collagen-binding proteins. M: PageRuler
TM
 #SM0671. Further details discussed in text. 
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The collagen binding activity was restricted to proteins in an area between pI 5.7 and 7.3, with a 
size range between 30 and 54 kDa (Figure. 3.5 B ii). The areas that are circled represent distinct 
spots of adhesion. Adhesion areas B to E were related to distinct protein spots, each of which 
was excised from the protein gels and subjected to LC MS/MS analysis (see details Chapter 4). 
 
Area A, at about 54 kDa was quite large. The corresponding area in the gel (Figure. 3.5A ii) had 
various spots in it. Only one of these was successfully isolated and analysed by LC MS/MS. This 
spot is identified in area A with an arrow. In the previous Far Western analyses performed 
(Figure. 3.3 and 3.4) only a very faint band was seen at this approximate size in first few lanes, 
between 54 and 55 kDa. The exact reason for this spot being so distinct in the 2D-SDS PAGE 
analysis is unclear. 
   
The areas boxed in black in figure 3.5 B (ii) were mainly streaks of adhesion rather than distinct 
spots and it was, therefore, not possible to relate them to spots in the protein gels. Box 1 was less 
streaky but the corresponding area of the protein gels was void of distinct protein spots. It should 
be noted that boxed areas 1 to 3 lie directly above the circled areas C, D and E respectively and 
could be the same adhesins which have been retained in the gel areas above.  
 
The questions that remain here are whether the boxed areas are distinct collagen adhesins or 
remnants of the spots below them. The size range of the boxed areas is of about 44kDa for box 1, 
36 to 45 kDa for box 2 and 43 to 50 kDa for box 3. These size ranges, and especially that of box 
1, are the most similar to the 45kDa adhesin band. It would appear that two-dimensional Far 
Western analysis of the CFE proteins would also be necessary in future work for elucidating the 
position of this adhesin.  
 
 
3.4 CONCLUSION 
 
In this chapter the aims were to use the best collagen binding strain available to us to determine 
the presence of specific collagen adhesins and to develop methods of isolating both these, and 
the collagen degrading proteins, for the purpose of identification by mass spectrometry. Various 
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methods for the separation of B. fragilis proteins were successfully used to isolate collagen 
adhesins, but they could not be used directly for the isolation of collagen proteases. An attempt 
was made to do 2D gel zymography of the OMPs, in which the second dimension was done 
using a polyacrylamide gel co-polymerised with collagen and then processed as described for 
normal zymograms (data not shown). No zones of collagen degradation were observed. This was 
not surprising as the protein samples in this method are exposed not only to trichloroacetic acid 
(TCA) treatment but also to harsh denaturants and reducing agents such as urea and dithiothreitol 
(DTT) with a resulting loss of activity.  
 
This inhibition of proteolytic activity was also problematic in the analysis of the affinity purified 
collagen adhesin fractions. The elution fractions obtained had a very low protein concentration 
and, in order to obtain samples that could be visualized on Coomassie stained SDS-PAGE, each 
elution fraction had to be precipitated using TCA. This treatment did not prevent the ability of 
the proteins to bind collagen but it completely abolished the collagenase activity of the samples.  
 
The various putative adhesin proteins excised from the gels were analyzed by mass spectrometry 
analysis in order to determine their identity. This analysis is discussed in detail in the following 
chapter. 
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Bioinformatic analysis of the LC MS/MS results of the putative 
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4.1 INTRODUCTION  
 
In this study, two techniques for the purification and isolation of collagen adhesins were 
employed (Chapter 3). These were affinity chromatography, using collagen as a ligand for 
adhesins found in the CFEs and OMP fractions, and 2D SDS-PAGE. Recognition of collagen 
binding proteins was done by subsequent collagen Far Western analysis. These methods were 
successful in isolating several proteins of interest. Table 4.1 below lists the bands and spots that 
were excised for further analysis and their origins.  
 
Table 4.1 Protein bands and spots excised for protein identification by LC MS/MS 
Figure number Protein fraction Purification/isolation method Band/spot 
Figure. 3.3 A CFE Affinity chromatography 
~44 kDa 
~45 kDa 
Figure. 3.4 A OMP Affinity chromatography 
~26 kDa 
~32 kDa 
Figure. 3.5 A 
(ii) 
OMP 2D SDS-PAGE 
~54 kDa (spot A) 
33 – 34 kDa cluster 
 (spots B to E) 
 
 
Liquid chromatography followed by tandem mass spectrometry (LC MS/MS) was the technique 
chosen for protein identification. This method is particularly useful for identifying proteins 
within protein mixtures (McCormack et al., 1997) and reduces the requirement for performing 
extensive protein purification. The analysis of the results is also greatly facilitated by the 
availability of the complete genomes of three B. fragilis strains, namely 638R, NCTC 9343 and 
YCH46 mentioned previously. This allows for the resulting peptide sequences to be directly 
compared to a species specific database of predicted proteins and the genes encoding them. 
 
This chapter describes the analysis of the LC MS/MS protein identification results and the choice 
of a putative collagen adhesin for further research.  
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4.2 METHODS 
 
4.2.1 LC MS/MS ANALYSIS OF PUTATIVE ADHESINS 
 
Protein bands excised from the affinity purification gels and protein spots excised from the 2-D 
PAGE gels (Chapter 3) were dried in eppendorf tubes for storage and transportation to the mass 
spectrometry service provider. The samples were sent to the Yale Cancer Centre Mass 
Spectrometry Resource & W.M. Keck Foundation Biotechnology Resource Laboratory in New 
Haven, Connecticut, United States of America. They were subjected to tryptic digestion followed 
by liquid chromatography and tandem mass spectrometry (LC MS/MS) analysis on a LTQ 
Orbitrap mass spectrometer (McCormack et al., 1997; Stone and Williams, 2009).  
 
 
4.2.2 DATA ANALYSIS 
 
The spectra from the LC MS/MS were analyzed by the service provider using the Mascot 
algorithm (Hirosawa et al., 1993). The genome sequences of B. fragilis available on NCBI were 
searched using the peak data generated, and the Mascot results were made available for the user 
on the YPED (Yale protein expression database) online viewing system.  
 
The criteria used by the service provider for protein identification was that 2 or more MS/MS 
spectra match the same protein entry in the database searched and that the matched peptides 
derive from the type of enzymatic digestion performed on the protein, in this case tryptic 
digestion. Particular attention was also drawn to the fact that s ince Ile / Leu are isomeric and 
Phe/oxMet and Gln / Lys are isobaric, differentiation between these amino acids was not 
possible, although a Gln/Lys in the middle of a peptide is most likely the Gln since a tryptic 
digest was done.  Proteins listed as matching with only 1 significant peptide match were not 
considered positive identifications and may simply be present in the sample  
 
NCBI and/or the MEROPS peptidase database (Rawlings et al., 2010) was used for BLAST 
analysis of the results. The PSI-BLAST algorithm (Altschul et al., 1997) was employed. 
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4.3 RESULTS 
 
A large amount of data was obtained from the LC MS/MS of the various protein gel bands and 
spots. Most of the results for each sample consisted of a mixture of various proteins which were 
represented to different extents in as much as the coverage of each is concerned. The selection of 
the most likely candidates for each sample is not a simple task. The proteins seen to have the 
highest score may not be the ones of interest but simply those found in higher amounts at the 
particular molecular weight, and pI, in the case of the 2D-separated proteins. On the other hand, 
if the protein which is responsible for the phenotype of interest is very abundant, it is likely to be 
found as a contaminant in another sample and even in the blank gel control.  
 
The results of the LC MS/MS are shown in Tables 4.2, 4.3 and 4.4. These exclude any results 
that were classified as “enzyme used for digestion”, “probable contaminant” or results that were 
only tentative due to only one peptide being used for the identification. Peptide matches below 
the homology or identity threshold of each sample were also excluded.  
 
Some the proteins represented in these tables were disregarded based on annotation that 
specifically implied a function that clearly had no link to the study, for example, the protein 
annotated as “DNA-directed RNA polymerase subunit alpha” of B. fragilis YCH46. Elimination 
based on apparent molecular weight discrepancies was, however, not possible due to the lack of 
knowledge about possible post-translational modifications of the proteins of interest. This is 
particularly true of the results obtained from the one dimensional gels as these were non-
reducing gels (i.e. no β-mercaptoethanol was used) and there was a possibility of unresolved 
disulphide bonds being present.  
 
Finally a large number of proteins annotated as hypothetical proteins were identified, each of 
which required more in-depth bioinformatic analysis before they could be either eliminated from 
the study or selected for further analysis.  
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4.3.1 AFFINITY PURIFIED ADHESINS OF THE CFEs 
 
Table 4.2 shows the results of the putative collagen binding proteins of 44 and 45 kDa that were 
purified from the CFE of B. fragilis GSH18 using collagen affinity chromatography (from 
Figure.3.3 A, Chapter 3). 
 
 
Table 4.2: Mass Spectroscopy Results of Affinity Purified adhesins of CFEs 
Band  Score  Expectation  Protein ID  Protein Name  MW 
(kDa) 
% 
Coverage 
44 kDa  1488 0 gi|53712081 hypothetical protein BF0788 [B. fragilis YCH46]  39.9 52.8 
 1244 4.6E-118 gi|53715321 major outer membrane protein OmpA BF4037 [B. fragilis 
YCH46] 
43.3 54.9 
 1161 8.8E-110 gi|253566135 citrate synthase [Bacteroides sp. 3_2_5] 50.9 37.6 
 782 7.1E-72 gi|53712366 hypothetical protein BF1074 [B. fragilis YCH46]  48.7 24.9 
 704 4.4E-64 gi|53712058 membrane-bound lytic murein transglycosylase D 
presursor [B. fragilis YCH46]  
49.0 25 
 651 8.9E-59 gi|53715439 DNA-directed RNA polymerase subunit alpha [B. fragilis 
YCH46] 
37.4 30.6 
 651 9.2E-59 gi|53714500 transcription termination factor Rho [B. fragilis YCH46]  76.6 21.3 
 589 1.4E-52 gi|53714920 glutamate dehydrogenase [B. fragilis YCH46]  48.3 36.4 
 569 1.3E-50 gi|60679959 hypothetical protein BF0371 [B. fragilis NCTC 9343] 48.4 27.1 
 568 1.8E-50 gi|53713031 chaperone protein DnaJ [B. fragilis YCH46]  42.2 23.9 
 434 4E-37 gi|53714555 phosphoglycerate kinase [B. fragilis YCH46]  45.1 19.1 
 336 2.5E-27 gi|53714597 putative multidrug resistance protein [B. fragilis YCH46]  39.0 24 
 303 5E-24 gi|53713703 TPR repeat-containing protein [B. fragilis YCH46]  46.5 16.1 
45 kDa  573 5.4E-51 gi|53715321 major outer membrane protein OmpA BF4037 [B. fragilis 
YCH46] 
43.3 32.9 
 409 1.3E-34 gi|29348149 elongation factor Tu [B. thetaiotaomicron VPI-5482]  43.6 16.8 
 280 9.9E-22 gi|53712480 phosphopyruvate hydratase [B. fragilis YCH46] 46.4 10 
 269 1.5E-20 gi|53715832 succinate dehydrogenase/fumarate reductase iron-sulfur 
subunit [B. fragilis YCH46]  
27.2 27.5 
 119 0.000013 gi|53714650 aminopeptidase C [B. fragilis YCH46] 44.1 5.6 
 248 1.6E-18 gi|53715707 bifunctional preprotein translocase subunit SecD/SecF [B. 
fragilis YCH46]  
110.0 4.2 
Blank 310 9.9E-25 gi|53715321 major outer membrane protein OmpA BF4037 [B. fragilis 
YCH46] 
43.3 17.2 
 190 1E-12 gi|53712081 hypothetical protein BF0788 [B. fragilis YCH46]  39.9 10.8 
Identity or homology score thresholds: 44 kDa (264); 45 kDa (81); Blank (38)  
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4.3.1.1  44 kDa BAND  
   
In this sample the best hit was a hypothetical protein BF0788 of B. fragilis YCH46. PSI-BLAST 
analysis of this protein sequence, however, yielded no putative function. This protein was also 
identified in the blank (10.8 % coverage) and for these reasons combined it was not analysed 
further in this study. The other results included the “major outer membrane protein OmpA” of B. 
fragilis YCH46 as well as two other hypothetical proteins, BF1074 of B. fragilis YCH46 and 
BF0371 of NTCT 9343. PSI-BLAST of the hypothetical proteins did not yield a putative 
function.  
 
The OmpA had the second best score and showed almost 55% coverage. The percentage 
coverage relates to the proportion of sequence of the particular protein that was covered by the 
sequence of the peptides generated from the LC M/MS analysis. Unfortunately, even though 
OmpA had quite a high coverage it was also the main protein found in the blank control (at 17% 
coverage). However, eliminating this candidate based on this information alone may be 
premature. It is not surprising that this protein was found in the blank control as OmpAs are the 
most abundant outer membrane proteins of B. fragilis (Pumbwe et al., 2007). Furthermore, 
OmpA has been suggested to be involved in the ability of various bacterial strains, including  
Bacteroides ovatus and B. fragilis, to bind human cells (Pumbwe et al., 2007; Sato et al., 2010). 
B. ovatus derived ompA genes, expressed in E. coli, increase the latter‟s ability to adhere to 
human cells (Sato et al., 2010).  
 
The OmpA homologue identified in the LC MS/MS was the B. fragilis YCH46 homologue of 
OmpA1, BF4037 (BF3810 of B. fragilis NCTC4343). This is one of seven ompA family gene 
homologues (Wexler et al., 2009). B. fragilis strains have shown increased ompA1 expression 
during exposure to bile-salt treatment, which coincided with an increase in adhesion to human 
epithelial cells (Pumbwe et al., 2007). The OmpA1 may be a good candidate for the ~45 kDa 
collagen adhesin. However, without being able to purify the collagen binding protein to greater 
homogeneity, for more accurate protein identification and mass determination, it is difficult to 
validate this possibility.  Furthermore, the only study where the involvement of OmpA-like 
proteins in collagen adhesion was investigated, reported that the homologue of Vibrio cholorae, 
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OmpU, could adhere to fibronectin but was unable to bind other matrix proteins such as collagen 
or laminin (Sperandio et al., 1995). The B. fragilis OmpA homologues have previously been the 
subject of functional studies via gene-specific mutagenesis (Wexler et al., 2009) and it would be 
interesting, in future studies, to investigate whether these mutants show any differences in 
collagen adhesion characteristics relative to the wildtype. However, in the current study, it was 
decided that further novel proteins would be investigated as described below.  
 
 
4.3.1.2  45kDa BAND 
 
The quality of the results for the 45 kDa band was relatively poor, in that after the elimination 
process only two putative candidates remained for consideration. The one with the better  score 
was the OmpA1 of B. fragilis YCH46 and, for the reasons discussed previously, was not 
considered further. The other candidate was a putative “aminopeptidase C” of a predicted 
molecular weight of about 44 kDa. In B. fragilis YCH46 this gene (BF3364) is shown to have a 
conserved C1 peptidase domain. When its predicted protein sequence was blasted on the 
MEROPS peptidase database (Rawlings et al., 2010), it was identified as being part of subfamily 
C1A peptidase. Even though the size of the protein is close to that of the larger collagenase band 
observed in the zymograms, it is unlikely to be responsible for the collagen proteolysis observed 
as collagenases are generally endopeptidases and not exopeptidases as is the case with 
aminopeptidases. 
 
 
4.3.2 AFFINITY PURIFIED ADHESINS OF THE OMP FRACTION 
 
The collagen affinity purification of the OMP fraction resulted in the isolation of two protein 
bands of ~26 and ~32 kDa with the ability to adhere to collagen (Figure. 3.4, Chapter 3).  
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Table 4.3: Mass Spectroscopy Results of Affinity Purified adhesins of the OMP 
Band  Score  Expectation  Protein ID  Protein Name  MW 
(kDa) 
% 
Coverage 
26kDa 1567 0 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 66 
 554 3.7E-49 gi|53715026 putative biopolymer transport protein [B. fragilis 
YCH46]  
28.9 36.6 
 313 5E-25 gi|60682546 hypothetical protein BF3077 [B. fragilis NCTC 9343]  22.0 39.9 
 287 2.2E-22 gi|60680892 hypothetical protein BF1378 [B. fragilis NCTC 9343] 21.8 33.3 
 152 5.9E-9 gi|53712509 hypothetical protein BF1217 [B. fragilis YCH46] 28.1 38.4 
 124 0.0000041 gi|53714054 hypothetical protein BF2762 [B. fragilis YCH46]  22.0 21 
 122 0.0000069 gi|253563053 conserved hypothetical protein [Bacteroides sp. 
3_2_5]  
37.6 7.3 
 110 0.000093 gi|53713187 OmpA family outer membrane protein BF1897       
[B. fragilis YCH46]  
23.1 9.8 
32kDa 1420 0 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 73.3 
 863 5.3E-80 gi|53712590 putative outer membrane protein BF1298                
[B. fragilis YCH46] 
42.3 29.4 
 625 3.2E-56 gi|53715321 major outer membrane protein OmpA [B. fragilis 
YCH46] 
43.3 33.9 
 466 2.7E-40 gi|254884606 predicted protein [Bacteroides sp. 4_3_47FAA] 27.8 41.6 
 390 9.5E-33 gi|53711673 hypothetical protein BF0382 [B. fragilis YCH46] 33.8 29.7 
 329 1.2E-26 gi|53712065 hypothetical protein BF0772 [B. fragilis YCH46]  27.8 36 
 323 5.2E-26 gi|53715463 50S ribosomal protein L2 [B. fragilis YCH46]  29.7 32.5 
 307 1.8E-24 gi|53713893 hypothetical protein BF2601 [B. fragilis YCH46]  54.8 13.8 
 259 1.1E-19 gi|53715026 putative biopolymer transport protein [B. fragilis 
YCH46]  
30.0 22 
 239 1.2E-17 gi|53714658 electron transfer flavoprotein beta-subunit [B. fragilis 
YCH46]  
31.1 14.1 
 212 5.6E-15 gi|53714795 hypothetical protein BF3510 [B. fragilis YCH46]  35.0 20.8 
 208 1.4E-14 gi|53711881 hypothetical protein BF0590 [B. fragilis YCH46]  27.5 14.7 
 183 4.6E-12 gi|33468445 hypothetical protein [B. ovatus]  40.5 13.7 
 183 4.9E-12 gi|53714576 hypothetical protein BF3290 [B. fragilis YCH46]  33.8 21.1 
Blank 842 5.9E-78 gi|50787940 putative plasminogen binding protein precursor [B. 
fragilis]  
61.4 39.3 
 299 1.3E-23 gi|53715321 major outer membrane protein OmpA BF4037        
[B. fragilis YCH46] 
43.3 24.1 
 234 3.9E-17 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 18.9 
 166 2.3E-10 gi|53713185 hypothetical protein BF1895 [B. fragilis YCH46]  71.3 10.2 
 150 1.1E-8 gi|53711959 hypothetical protein BF0669 [B. fragilis YCH46]  56.8 9.9 
 128 0.0000017 gi|53713013 hypothetical protein BF1724 [B. fragilis YCH46]  59.5 4.4 
 121 0.0000079 gi|53711863 hypothetical protein BF0572 [B. fragilis YCH46]  24.3 13.3 
Identity or homology score thresholds: 26 kDa (106); 32 kDa (181); Blank (109)  
 
For both the 26 kDa and the 32 kDa samples the highest hit obtained was a hypothetical protein, 
BF0662, of B. fragilis YCH46. The Mascot coverage maps shown in Figure 4.1 revealed that the 
peptide sequences obtained for sample 33 kDa covered about 73% of the sequence (seen in red) 
of this hypothetical protein, whereas those for 26 kDa only covered about 66%. Most 
significantly, this 66% coverage seen for the smaller protein was restricted to the C-terminal end 
of the protein sequence after about the 70th amino acid, whereas the peptides obtained from the 
larger band extended to almost the 30th amino acid. This suggested that the 26kDa band might be 
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a processed form of the BF0662 homologue, or even a degradation product of the full length 
protein. The fact that this smaller version was still able to adhere to collagen hints at the presence 
of a binding domain towards the C-terminal side of the protein.  
 
A 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
Figure 4.1 BF0662 MASCOT Coverage maps for affinity purified OMP samples (A) 26 kDa and (B) 33 
kDa protein bands. The sequences in red denote the peptide sequence coverage.  
 
 
In spite of encoding an unknown hypothetical protein, the BF0662 homologue appeared to be the 
best candidate based on percentage coverage as well as its predicted molecular mass. However, 
several other hypothetical proteins were also available for consideration. The OmpA1 was only 
found in the blank control, but two other OmpAs were observed, one in each of the experimental 
samples. In the 26 kDa sample, the OmpA6 homologue of B. fragilis YCH46, BF1897 (BF1959 
of B. fragilis NCTC4343), was present but it had a very low score and a coverage of only 9.8%. 
The B. fragilis YCH46 OmpA3 homologue, BF1298 (BF1285 of B. fragilis NCTC4343), present 
in the 32 kDa sample, showed a much higher coverage (29.4 %), however this protein has an 
predicted size of about 43 kDa which is significantly higher than that estimated for the adhesin.  
None of these other candidates, however, had nearly as high a score and coverage as BF0662 and 
none were present in both samples. It should be noted that, although, BF0662 was also present in 
the blank, the coverage was only 19% suggesting that in this sample it was a low level 
contaminant. 
1      MKKLAILLVC AAMLASCNGL GGGSKDLKAE NDSLLMELTQ RNAELDEMMG TFNEVQEGFR 
61     KINAAESRVD LTRGTISENS ATAKQQIASD IEFITKQMEE NKAQIAKLQA MLKSSKNNSA 
121    QLKKAVESLT QELVAKTQRI EELQAELASK NIRIQELDAA VTGLTADKES LAAENEAKAK 
181    TVAEQDKAIN SAWFVFGTKS ELKTQKILEK GDVLKSADFN KDYFTQIDIR TTKEIKLYSK 
241    RAELLTTHPA KSYELVKDDK GQLTLKITNP KEFWSVSKYL VIQVK 
1      MKKLAILLVC AAMLASCNGL GGGSKDLKAE NDSLLMELTQ RNAELDEMMG TFNEVQEGFR 
61     KINAAESRVD LTRGTISENS ATAKQQIASD IEFITKQMEE NKAQIAKLQA MLKSSKNNSA 
121    QLKKAVESLT QELVAKTQRI EELQAELASK NIRIQELDAA VTGLTADKES LAAENEAKAK 
181    TVAEQDKAIN SAWFVFGTKS ELKTQKILEK GDVLKSADFN KDYFTQIDIR TTKEIKLYSK 
241    RAELLTTHPA KSYELVKDDK GQLTLKITNP KEFWSVSKYL VIQVK 
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4.3.3 2D SDS-PAGE SEPARATED ADHESINS OF THE OMP FRACTION 
 
The OMP fraction was also separated by 2D SDS-PAGE (Figure. 3.5, Chapter 3). This 
technique, combined with collagen Far Western analysis, allowed for the identification five 
adhesin spots which were excised and analyzed by LC MS/MS. These were a protein spot of 
about 54 kDa, designated spot A, and four spots between 33 and 34 kDa, designated B to E 
(Table 4.4).  
 
 
4.3.3.1  SPOT A (54 kDa) 
 
The BF0662 homologue was present in every sample analysed from the 2D SDS-PAGE but this 
time not in the blank. This indicates that it is probably a very ubiquitous protein. However, the 
size discrepancy between spot A (~54 kDa) and the BF0662 homologue (~32 kDa) was quite 
significant and, therefore, it was unlikely that it was responsible for the phenotype of this spot 
(A). The highest scoring result for this spot had a more convincing predicted size of 52kDa but 
was a hypothetical protein of unknown function, BF1955 of B. fragilis YCH46. BF0662 was the 
second highest scoring and the third was a serine protease precursor with a predicted size of 
about 55 kDa. Various other hypothetical protein candidates of unknown function and similar 
size were also present, as well as the putative plasminogen binding protein.  
 
The most interesting annotated proteins were the plasminogen binding protein (Pbp) and the 
serine protease precursor. The first has been studied in B. fragilis, and was shown to be a 
plasminogen and laminin binding protein that is also responsible for the conversion of 
plasminogen to plasmin (Ferreira et al., 2009; Sijbrandi et al., 2008). This proteolytic activation 
process is discussed in detail in Chapter 1. The Pbp has been shown to be processed to an active 
form of 59.4 kDa from its original 60 kDa propeptide form (Sijbrandi et al., 2008). Spot A is, 
therefore, too small to correspond to this protein.  Furthermore the putative Pbp was also found 
in spots A to D and has been seen in the blanks of the other gels (Tables 4.2 and 4.3). Although it 
was not apparent in the 2D SDS-PAGE blank, it still did not appear to be an ideal candidate in 
this case. 
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Table 4.4: Mass Spectroscopy Results of 2D-separated adhesins of OMP fraction 
Spot  Score  Expectation  Protein ID  Protein Name  MW 
(kDa) 
% 
Coverage 
A 1948 0 gi|53713245 hypothetical protein BF1955 [B. fragilis YCH46] 52.1 55.6 
 1026 1.5E-96 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 49.1 
 806 1.5E-74 gi|53715426 outer membrane efflux protein [B. fragilis YCH46]  50.3 29.8 
 790 6.2E-73 gi|53714036 serine protease precursor [B. fragilis YCH46] 54.7 31.8 
 784 2.6E-72 gi|53711771 alkaline phosphatase III precursor [B. fragilis YCH46]  50.9 25.1 
 738 9.6E-68 gi|255010805 hypothetical protein Bfra3_16818 [B. fragilis 3_1_12] 47.7 30.4 
 698 9E-64 gi|50787940 putative plasminogen binding protein precursor [B. fragilis]  61.4 22.9 
 637 1.3E-57 gi|53713428 hypothetical protein BF2139 [B. fragilis YCH46] 50.1 30 
 633 3.2E-57 gi|53711971 putative outer membrane protein TolC [B. fragilis YCH46]  50.4 23.6 
 469 8.1E-41 gi|29349753 30S ribosomal protein S1 [B. thetaiotaomicron VPI-5482]  67.0 11 
 379 8E-32 gi|53715071 putative chitobiase [B. fragilis YCH46]  48.2 25 
 314 2.2E-25 gi|189468231 hypothetical protein BACINT_04627 [B. intestinalis DSM 
17393] 
50.6 14.5 
 237 1.3E-17 gi|53713300 Na(+)-translocating NADH-quinone reductase subunit A [B. 
fragilis YCH46]  
49.3 14.2 
B 1739 0 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 64.9 
 646 1.4E-58 gi|50787940 putative plasminogen binding protein precursor [B. fragilis]  61.4 23.4 
 405 2E-34 gi|53715620 leucine aminopeptidase precursor [B. fragilis YCH46] 37.1 29.3 
 227 1.2E-16 gi|53715740 hypothetical protein BF4461 [B. fragilis YCH46]  77.1 5.3 
 212 4E-15 gi|53713245 hypothetical protein BF1955 [B. fragilis YCH46]  52.1 9.4 
 203 2.8E-14 gi|53713922 hypothetical protein BF2630 [B. fragilis YCH46]  32.7 12.4 
C 593 3.2E-53 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 42.8 
D 1230 5.5E-117 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 55.4 
 945 1.8E-88 gi|53712468 hypothetical protein BF1176 [B. fragilis YCH46] 35.9 48.3 
 848 9.1E-79 gi|53715321 major outer membrane protein OmpA BF4037 [B. fragilis 
YCH46] 
43.3 32.4 
 559 8.2E-50 gi|50787940 putative plasminogen binding protein precursor [B. fragilis]  61.4 19.4 
 353 3.2E-29 gi|53714795 hypothetical protein BF3510 [B. fragilis YCH46]  35.0 33 
 295 1.8E-23 gi|53712259 glyceraldehyde 3-phosphate dehydrogenase [B. fragilis YCH46]  35.6 23.7 
 279 7.4E-22 gi|53712060 putative chromosome partitioning protein ParB [B. fragilis 
YCH46] 
33.6 17.6 
 227 1.1E-16 gi|53715425 cation efflux system protein [B. fragilis YCH46]  37.1 10.7 
E 877 1.4E-81 gi|53715832 succinate dehydrogenase/fumarate reductase iron-sulfur subunit 
[B.fragilis YCH46] 
27.2 59.8 
 804 2.4E-74 gi|53715321 major outer membrane protein OmpA [B. fragilis YCH46] 43.3 42 
 710 5.9E-65 gi|53711952 hypothetical protein BF0662 [B. fragilis YCH46] 31.6 37.2 
 287 1.1E-22 gi|53711479 UDP-N-acetylglucosamine acyltransferase [B. fragilis YCH46] 27.9 27.7 
 274 2.5E-21 gi|53713932 putative glycerophosphodiester phosphodiesterase [B. fragilis 
YCH46] 
28.5 28.5 
 268 9.9E-21 gi|53712899 hypothetical protein BF1609 [B. fragilis YCH46]  54.3 15.6 
 244 2.6E-18 gi|53714795 hypothetical protein BF3510 [B. fragilis YCH46]  35.0 19.9 
 185 1.9E-12 gi|60682598 hypothetical protein BF3129 [B.fragilis NCTC 9343] 33.9 19.4 
Blank 155 3.6E-9 gi|53713184 outer membrane protein Omp121 [B.fragilis YCH46]  124.6 3.3 
 95 0.0035 gi|53715321 major outer membrane protein OmpA BF4037 [B.fragilis 
YCH46] 
43.3 9.9 
Identity or homology score thresholds: A (211); B (184); C (22); D (200); E (139); Blank (26)  
 
 
The serine protease precursor candidate is a homologue of the BF2744 gene of B. fragilis 
YCH46, which corresponds to BF2761 of strain NCTC 9343 and BF638R2772 of strain 638R. 
This open reading frame (ORF) has an expected size of about 55 kDa and is annotated as a 
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trypsin- like serine protease of the DegP/HtrA family. This family has been extensively studied in 
various bacterial and eukaryotic species and is characterized by trypsin- like catalytic domain 
with one or more PDZ domains, responsible for protein-protein interactions (Clausen et al., 
2002). These are highly conserved proteins with protease and chaperone activity, located in the 
periplasm of gram negative bacteria. They are responsible for ensuring misfolded proteins are 
degraded and that outer membrane proteins are carried through the periplasm (Ingmer and 
Brondsted, 2009).  
 
A 
 
 
 
B 
 
 
 
 
 
 
Figure 4.2 Genomic context of the putative serine protease precursor of B. fragilis YCH46. (A) 
Arrangement of genes in B. fragilis YCH46; (B) ORF numbers and gene annotation in B. fragilis strains 
YCH46, NCTC9343 and 638R 
 
 
HtrA serine proteases are known to contribute to pathogenesis in various ways. In E. coli they 
are responsible for resistance to temperature and oxidative shock (Pallen and Wren, 1997). HtrA 
was found to be needed for systemic infection of mice by Salmonella typhimurium and similarly 
for cell-to-cell translocation by Shigella flexneri. In Campylobacter jejuni, HtrA appears to 
stimulate adherence to gastrointestinal epithelial cells (Ingmer and Brondsted, 2009). The only 
published report of this protein interacting with collagen involved the interaction of the 
mammalian HtrA1 protease with C-propeptides of fibrillar collagens. Here it was found to bind 
various C-propeptides of fibrillar collagens, including type I, and to degrade type III procollagen 
α 1 C-propeptide (Murwantoko et al., 2004). No such interaction has been reported for bacterial 
HtrA type proteins.  
YCH46 ORF  NCTC 9343 ORF 638R ORF  GENE DESCRIPTION 
BF2747 BF2764 BF638R2772 Dipeptidyl peptidase VI 
BF2746 BF2763 BF638R2771 Muconate cycloisomerase 
BF2745 BF2762 BF638R2770 Putative cystein protease 
BF2744 BF2761 BF638R2769 Serine protease precursor 
BF2743 BF2760 BF638R2768 Hypothetical protein 
BF2742 BF2759 BF638R2767 RNA polymerase factor RpoD 
BF2741 BF2758 BF638R2766 Hypothetical protein 
BF2740 BF2757 BF638R2765 Clostripain-related protein 
BF2740        BF2741                    BF2742              BF2743                                 BF2744                                                    BF2745                             BF2746             BF2747 
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It seems unlikely that this protein is responsible for the type of collagen adhesin and protease 
properties observed in B. fragilis in this study, but it may play a role in other proteolytic 
pathways in light of its genomic context in B. fragilis. Figure 4.2 shows the arrangement of the 
genes (Figure. 4.2.A) and how they are conserved between three B. fragilis strains (Figure 
4.2.B). In this gene cluster there are three more proteins annotated as putative peptidases, 
including the clostripain protein candidate (BF638R2765) mentioned in Chapter 2 (Table 2.3).  
 
 
4.3.3.2  33-34kDa cluster – SPOTS B to E 
 
Spots B to E each have the BF0662 hypothetical protein of B. fragilis YCH46 as their highest 
hit, with spot B having a coverage of about 65%. These results correlate well with those of the 
affinity purified adhesins of the OMP fraction (Section 4.3) where the 33 kDa band also shows 
the presence of the BF0662 homologue.  
 
Other proteins identified in these samples again include OmpA1 and the putative plasminogen 
binding protein. Various hypothetical proteins of unknown function were also present, as well as 
a putative leucine aminopeptidase precursor of B. fragilis YCH46. This putative 
metallopeptidase has a predicted molecular weight of about 37kDa and has a conserved M28 
peptidase domain as identified using the MEROPS peptidase database 
(http://merops.sanger.ac.uk/index.shtml) (Rawlings et al., 2010). Even though the size of the 
protein is close to that of the smaller 37 kDa, collagenase band observed in the zymograms in  
Chapter 3 (Figure 3.2 B), it is again not an endopeptidase and thus unlikely to be responsible for 
the collagen proteolysis observed.  
 
 
4.4. CONCLUSION 
 
Having successfully separated the a number of collagen binding proteins of B. fragilis for the 
purpose of mass spectrometric analysis, a through analysis of these results had to be performed 
in order to determine whether there were any putative collagen adhesin and/or protease gene 
candidates which could be responsible for the production of the collagen adhesins and proteases 
observed in previous chapters.   The mass spectroscopy results discussed in this chapter present a 
wealth of information about a subset of outer membrane proteins being expressed in B. fragilis. 
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Several candidates which may function as collagen adhesins were identified, namely the major 
outer membrane protein, OmpA1, and the putative plasminogen binding protein, Pbp. As 
discussed above, there were various considerations which excluded them from being investigated 
further in this study. These included size discrepancies and their presence in the blank control 
and in samples obtained from areas of very different molecular weight range. This was 
particularly true in the case of OmpA1 which was always present in the blanks of all the gels 
analysed. Pbp was found only once in a blank but was also found in areas with much smaller 
molecular weight proteins, which could be the result of the presence of degradation products of 
this protein. In spite of this, both of these have been implicated in the ability of B. fragilis to 
adhere to human cells or components of the ECM and may be worth investigating further in a 
follow up study in terms of their relationship to collagen.  
 
The HtrA-like serine protease, identified in the 2D SDS-PAGE separated spot A, of ~54kDa, 
showed that at least one protein of a putative protease cluster was being expressed in B. fragilis. 
The last gene of the cluster, the clostripain- like protein coding gene, appears to be a good 
candidate for a collagenase. However, an insertional mutant of the putative clostripain- like gene, 
produced when attempts at identifying putative collagenase genes from genome annotation were 
made (Chapter 2, data not shown), did not show the loss of any of the protease activity bands 
seen in this study. This gene might, however, still encode an active protease with alternative 
substrate specificity and different activation buffer requirements. Further analysis of this gene 
cluster would be of interest especially in light of this mass spectroscopy information. 
 
The hypothetical protein BF0662 of B. fragilis YCH46 was repeatedly found as the principal 
component of the samples analysed, especially those of the size range o f the 32 – 34 kDa 
doublet. This protein had a predicted molecular weight (31.6 kDa) which was in the correct 
range for the adhesin as determined by one dimensional SDS-PAGE. The observation that the   
26 kDa band, obtained during affinity purification of OMP, showed peptides that covered only 
the C-terminal side of the protein was an interesting fact that could hint at the position of the 
collagen binding domain of this adhesin. For these reasons the BF0662 homologue was chosen 
as the candidate gene for further genetic and functional investigations in this study. This work is 
described in Chapter 5. 
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5.1 INTRODUCTION  
 
The discovery of B. fragilis collagen adhesins by Far Western analysis of the cell free extracts 
and outer membrane protein fractions was described in previous chapters. Three distinct adhesin 
bands were seen, of approximately 32, 34 and 45 kDa respectively. These were isolated by 
affinity chromatography and 2D SDS-PAGE and then analyzed by LC-MS/MS. The ORF 
BF0662 of B. fragilis YCH46, was found to be the most likely candidate gene for the production 
of the ~32 kDa adhesin. For the purpose of this study, the BF0662 homologue in strain GSH18 
has been named cbp (collagen binding protein). 
 
In B. fragilis YCH46, the Cbp coding gene was annotated as a hypothetical protein and further 
comparison of its predicted protein sequence with proteins lodged in the database of the National 
Centre for Biotechnology Information (NCBI) did not yield any further information of the 
putative function of this gene.  
 
Gene specific mutagenesis is a useful technique for identifying the function of a gene of interest 
in the bacterium under investigation. In B. fragilis, insertional mutagenesis (Shoemaker et al., 
2000), has been established as a reliable method for this purpose. The resulting mutant can be 
compared to the wild-type strain using the two methods used previously to identify the collagen 
adhesin, namely one dimensional SDS-PAGE and 2D SDS-PAGE followed by Far Western 
analysis in order to determine whether the genetic mutation has lead to the loss of ~32 kDa 
adhesin band.   
 
In order to confirm that a specific gene encodes a protein with a particular function, the gene can 
be cloned into an over-expression vector for the heterologous production of the protein in E. coli. 
The appearance of a novel collagen adhesin in the recombinant strain would confirm cbp as the 
gene responsible for the production of the collagen binding protein of interest.  
 
This chapter, therefore, describes the functional characterization of the cbp gene, and the 
expressesed Cbp protein, in B. fragilis GSH18 and E. coli respectively. 
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5.2 MATERIALS AND METHODS  
 
5.2.1 BACTERIAL STRAINS AND GROWTH CONDITONS 
 
The bacterial strains and plasmids used in this chapter are described in Table 5.1. below.           
B. fragilis strains were maintained on BHIS agar and broth as described in Chapter 2, except 
during transconjugant selection following mutagenesis (section 5.2.2) when the BHIS agar was 
supplemented with gentamycin (200 µg/ml) and erythromycin (10 µg/ml).  E. coli strains were 
grown in Luria-Bertani (LB) broth or agar, aerobically, at 37°C (Maniatis et al., 1982) 
supplemented with ampicillin (100 µg/µl) or kanamycin (30 µg/µl) when necessary.  
 
Table 5.1. Description of bacterial strains and plasmids  
Strain/Plasmid Genotype/phenotype Source/reference 
Plasmids   
pGERM pUC19-based suicide vector (Shoemaker et al., 2000) 
pGERMcbp-int pGERM containing cbp internal fragment This study 
pTZ57R/T Poly-T tailed cloning vector with 3‟-ddT 
overhangs. lacZa oriE.coli .  Amp
R
 
Fermentas 
pTZ57cbp pTZ57R/T containing the cbp gene. Amp
R
 This study 
pET29b(+) IPTG-inducible E. coli expression vector 
containing a N-terminal S-Tag and a C-
terminal hexahistadyl tag. Kan
R
 
Novagen 
pETcbp pET29b(+) containing the cbp gene in-frame 
to sequences encoding the S-Tag and the 
hexahistadyl tag. Kan
R
 
This study 
Strains   
Bacteroides fragilis   
GSH18 Clinical isolate, Gent
R
 This study 
GSH18 cbp
-
 GSH18 derivative, cbp
-
, Gent
R
Erm
R
 This study 
Escherichia coli   
S17-1 RP4-2-Tc::Mu aph::Tn7recA
-
, Strep
R
 (Simon et al., 1983) 
S17-1 pGERMcbp-int RP4-2-Tc::Mu aph::Tn7recA
-
, Strep
R
Amp
R
 This study 
BL21(DE3) F
- 
ompT hsdSB (rB
- 
mB
-
) gal dcm (DE3) (Studier and Moffatt, 
1986) 
BL21(DE3) pET29b(+) F
- 
ompT hsdSB (rB
- 
mB
-
) gal dcm (DE3). Kan
R
 This study 
BL21(DE3) pETcbp F
- 
ompT hsdSB (rB
- 
mB
-
) gal dcm (DE3). Kan
R
 This study 
GentR, ErmR, StrepR, AmpR and RifR denote resistance to gentamycin, erythromycin, streptomycin, ampicillin and 
kanamycin respectively  
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5.2.2 INSERTIONAL MUTAGENESIS OF HOMOLOGUE OF cbp 
 
A 0.339 kb fragment corresponding to an internal region of the cbp gene, beginning at base 43 
and terminating at base 381, was PCR amplified using the primers BF0662-Fstop and BF0662-
Rstop (Table 5.2). Translation stop codons were designed into these primers to ensure that no 
truncated version of the Cbp protein was produced by the recognition of a Bacteroides type 
promoter sequence in the pGERM insert by a B. fragilis RNA polymerase. The product was then 
cloned into the SmaI site of the suicide vector pGERM by blunt cloning according to standard 
protocols (Maniatis et al., 1982). The insert was sequenced from the recombinant plasmid 
pGERMcbp-int using M13 primers as described in Chapter 2. 
 
The recombinant plasmid was transformed into E. coli S17-1 CaCl2 competent cells (Dagert and 
Ehrlich, 1979).  The plasmid pGERMcbp-int was then transferred into B. fragilis GSH18 cells by 
conjugation as described previously in Chapter 2.  
 
 
Table 5.2. Description of PCR primers 
Name Primer  *Hyb  T° Fragment 
size (kb) 
Description 
BF0662-Fstop 
 
BF0662-Rstop 
5'-GCTTAGTGTAACGGCCTGG-3' 
         
5'-ACTCAACAGCCTTCTACAGC-3' 
52.1°C 
 
50.4°C 
0.339 kb  Primer pair amplifies 
an internal fragment 
of BF0662 of B. 
fragilis YCH46 gene 
homologue; cbp.  Stop 
codons are bolded 
with altered bp 
underlined. 
BF0662-F2PET 
 
 
BF0662-R2PET 
5'-AAATGTAATCCCATGGAAAAGTTAGC-3' 
                                   (NcoI) 
 
5'-TTACTCGAGTTGGATAACCAAATAC-3' 
                (XhoI) 
51.0°C 
 
 
50.7°C 
0.87 kb  Primer pair amplifies 
the full length BF0662 
of B. fragilis YCH46 
gene homologue; cbp.  
Restriction enzyme 
sites (in brackets) are 
bolded with altered bp 
underlined. 
*Hyb T°. Hybrid ization temperature 
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5.2.3 CONFIRMATION OF INSERTION 
 
Confirmation of mutagenesis was done by PCR of erythromycin and gentamycin resistant         
B. fragilis transconjugant colonies, using M13 forward and reverse primers (Table 2.2), internal 
to the pGERM vector, and primers for the full length gene, BF0662-F2PET and BF0662-R2PET 
(Table 5.2). The PCR products obtained from the mutant colonies, using M13R with BF0662-
F2PET, and M13F with BF0662-R2PET, and from wild-type GSH18 colonies using BF0662-
F2PET with BF0662-R2PET, were sequenced by Macrogen Inc., Seoul, Korea. Sequencing was 
done using M13R and M13F primers for the respective mutant PCR products and BF0662-
F2PET and BF0662-R2PET for the wild-type PCR product. The resulting sequences were 
analyzed using DNAMAN (version 4.13). 
 
 
5.2.4 COLLAGEN FAR WESTERN ANALYSIS AND ZYMOGRAPHY 
 
The CFE and OMP fractions of the wild-type B. fragilis GSH18 and the GSH18 cbp- mutant 
were extracted using the methods described in Section 3.2.4 and compared by Far Western 
analysis as per Section 3.2.5. Collagen zymography was performed on the same samples as 
described in Section 2.2.5.  
 
Collagen Far Western analysis of the E. coli BL21(DE3) (pETcbp) and E. coli BL21(DE3) 
(pET29b(+)) protein extracts (Section 5.2.6) was performed to assesses the collagen binding 
ability of CbpHis. 
 
 
5.2.5 TWO-DIMENSIONAL GEL ELECTROPHORESIS  
 
The outer membrane protein fractions of the wild-type B. fragilis GSH18 and the GSH18cbp- 
mutant were separated by 2D SDS-PAGE as described in section 3.2.8. Collagen Far Western 
analysis of the wild-type and mutant proteins on the gel was performed and the presence or 
absence of collagen binding proteins was compared.  
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5.2.6 OVEREXPRESSION AND EXTRACTION OF CbpHis  
 
The B. fragilis GSH18 cbp gene was PCR amplified using primers BF0662-F2PET and BF0662-
R2PET (Table 5.2). PCR reactions were done as per Section 2.2.10. The PCR product was 
purified using the BioSpin PCR Purification Kit (BioFlux. Cat# BSC03S1), as per the 
manufacturer‟s instructions, and ligated into the TA-tailed vector pTZ57R/T using the 
InsTAclone PCR Cloning Kit (Fermentas) to produce the plasmid pTZ57cbp. The cbp gene was 
then subcloned into the pET29b(+) protein expression vector by digestion of the pTZ57cbp 
plasmid with NcoI and XhoI restriction enzymes (Fermentas) and subsequent ligation into these 
sites in pET29b(+). Confirmation that the gene was in frame with the pET29b(+) encoded His 
and S-tags was obtained by sequencing of the resulting clone, pETcbp.    
 
The overexpression of CbpHis was done based on the methodology outlined in the pET System 
Manual (Novagen) with various modifications. Briefly, 50 ml of LB with kanamycin was 
inoculated with E. coli BL21(DE3) pETcbp (CbpHis expressor) and grown to an OD600nm of 
between 0.4 and 0.6. Expression of the protein was then induced for 2 h by addition of IPTG (0.5 
mM). The same procedure was followed for E. coli BL21(DE3) containing pET29b(+) which 
was used as a negative control.  
 
Four ml of induced culture were collected by centrifugation in an Eppendorf 5415C bench top 
centrifuge (14 000 rpm or 16 000 g, RT, 10 min), the cell pellet resuspended in 200 µl PBS, and 
the cells disrupted by sonication using a Misonic sonicator 3000 at a power output of 3 W for 5 
rounds of 30 s. The cell lysate was centrifuged in an Eppendorf 5415C bench top centrifuge (14 
000 rpm or 16 000 g, 4°C, 10 min) and the cell debris and supernatant were collected. The 
supernatant, or CFE, was designated as the soluble fraction, and the cell debris as the insoluble 
fraction. The insoluble fraction was resuspended in 200 µl PBS.  
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5.2.7 HIS-TAG WESTERN ANALYSIS 
 
To confirm the expression of CbpHis, the E. coli BL21(DE3) (pETcbp) and E. coli BL21(DE3) 
(pET29b(+)) protein extracts (Section 5.2.6) were tested by Western blot analysis using          
anti-6-His antibodies (Sambrook et al., 2001).  Fifteen microliters  of each protein sample was 
mixed in a 1:1 ratio with 2X SDS gel loading buffer (without β-mercaptoethanol) (0.125M Tris-
HCl [pH 6.8], 4% SDS, 20% glycerol, 0.002% bromophenol blue) and incubated at room 
temperature for 10 min prior to electrophoresis in a 12% SDS (w/v) polyacrylamide gel (without                          
β-mercaptoethanol) (Laemmli, 1970). PageRulerTM Prestained Protein Ladder (Fermentas, 
#SM0671) was used as the molecular weight standard for all protein gels. Duplicate protein gels 
were prepared, where one was stained with Coomassie brilliant blue, and the other was 
transferred on to a nitrocellulose membrane using the Trans-Blot® SD DNA/RNA Blotting Kit 
(Bio-Rad) as per the manufacturer‟s instructions.   
 
The nitrocellulose blots were blocked overnight by incubating at room temperature (RT) in 
blocking buffer (1X PBS buffer, pH7.4, 0.1% Tween 20, 5% skim milk). The membranes were 
then incubated with affinity purified rabbit anti-6xHis (1:5000) (GeneTex. GTX77352) for 1 h at 
RT and washed four times with blocking buffer. This was followed by incubation with 
peroxidase conjugated anti-rabbit IgG (Goat) antibody (1:2500) (Gene Tex, GTX77060) for 1 h 
at RT and four washes with blocking buffer without skim milk. The membrane was then 
developed with TMB Membrane Peroxidase substrate (KPL, 50-77-18). 
 
 
 5.3. RESULTS AND DISCUSSION 
  
5.3.1. INSERTIONAL MUTAGENESIS 
 
Insertional mutation of the putative collagen adhesin gene, named here cbp, was the first step in 
determining whether it was responsible for the production of the ~32 kDa collagen adhesin of 
B.fragilis GSH18. A fragment of approximately 0.3 kb was used as the gene specific target 
region for disruption (Figure. 5.1). To confirm the insertion of the suicide vector into the gene of 
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interest, PCR of the putative transconjugants was performed using primers for the full length 
gene, in combination with M13 primers which bind to the pGERM vector sequence.  
 
 
(A) Wild-type GSH18 cbp 
 
 
 
 
(B) GSH18 cbp- Mutant 
 
 
 
 
Figure 5.1 Schematic diagram of the targeted gene disruption. (A) Wild-type B. fragilis GSH18 cbp 
expected PCR products; (B) B. fragilis GSH18 cbp
-
 mutant expected PCR products. The light blue area 
indicates the internal fragment of the cbp gene used for the homologous recombination. The dark blue 
area is the rest of the cbp gene. The black area represents the pGERM plasmid DNA and the arrows 
indicate the primers used and their annealing sites. 
 
 
The cbp gene was indeed interrupted, as confirmed by the production of 0.43 kb and 0.87 kb 
PCR fragments with primers BF0662-F2PET and M13R, and BF0662-R2PET and M13F 
respectively (Figure. 5.2, lanes 6 and 8 respectively). These fragments were not produced when 
wild-type colonies were used (lanes 7 and 9). PCR with BF0662-F2PET and BF0662-R2PET 
amplified the full length cbp gene from wild-type B. fragilis GSH18 (lane 3) and not from the 
mutant (lane 2).  
 
BF0662-F2PET 
BF0662-R2PET 
BF0662-F2PET 
BF0662-R2PET M13R 
M13F 
0.87kb 
0.87kb 0.43kb 
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Sequencing of the mutant PCR products (Figure. 5.2. Lanes 6 and 8) with primers M13F and 
M13R confirmed the junction between the pGERM inserted vector and the interrupted cbp gene. 
The presence of the stop codons, designed into the BF0662-F2stop and BF0662-R2stop, was also 
confirmed. 
 
                    Ma     1       2       3       4       5                                                 Mb     6      7       8       9      10     11   
                         
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 PCR of DNA from wild-type B. fragilis GSH18 and B. fragilis GSH18 cbp- mutant for 
confirmation of insertion. Lanes: (Ma) molecular weight marker of λ-phage DNA digested with PstI; 
(Mb) molecular weight marker O‟GeneRulerTM 100bp DNA Ladder (Fermentas #SM1143); Primers 
BF0662-F2PET and BF0662-R2PET with (1) no DNA template; (2) mutant DNA; (3) wild-type DNA; 
Primers BF0662-F2PET and M13F with (4) mutant DNA; (5) wild-type DNA; Primers BF0662-F2PET 
and M13R with (6) mutant DNA; (7) wild-type DNA; Primers BF0662-R2PET and M13F with (8) 
mutant DNA, (9) wild-type DNA; Primers BF0662-R2PET and M13R with (10) mutant, (11) wild-type. 
 
 
5.3.2 ADHESIN & PROTEASE PROFILE OF MUTANT AND WILD-TYPE 
   
A comparison of the collagen adhesin and protease profiles of the B. fragilis GSH18 cbp- mutant 
with that of the wild-type B. fragilis GSH18 was performed to establish if the cbp gene coded for 
the production of the 32 kDa adhesin protein. A complete analysis of the cbp- mutant‟s ability to 
bind to or degrade collagen, was done using the previously established methods of collagen Far 
Western analysis and collagen zymography. Both the CFEs (Figure. 5.3) and OMP fractions      
(Figure. 5.4) of the B. fragilis GSH18 wild-type and cbp- mutant strains were investigated.  
0.9 kb 
 
0.7 kb 
  
0.5 kb 
0.4 kb 
 
 
 
11.5 kb 
 
 
2.84 kb 
 
1.7 kb 
  
1.09 kb 
 
0.81 kb 
 
0.87 kb 0.87 kb 
 
 
0.43 kb 
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  A                                                        B                                                    C  
 
        M          WT                MUT                WT                 MUT                           WT                 MUT 
 
 
 
 
 
Figure 5.3 Collagen Far Western blot and zymogram comparisons of B. fragilis GSH18 wild-type (WT) 
and  B. fragilis GSH18 cbp
-
 mutant (MUT) CFEs. (A) Coomassie stained SDS-PAGE, (B) Collagen Far 
Western, (C) Collagen zymogram. M: PageRuler
TM
 #SM0671  
 
 
A                                                        B                                                   C 
 
         M        WT                 MUT                WT              MUT                                 WT               MUT 
 
 
 
 
 
 
 
Figure 5.4 Collagen Far Western blot and zymogram comparison of wild-type B. fragilis GSH18 (WT) 
and  B. fragilis GSH18 cbp- mutant (MUT) outer-membrane protein fraction. (A) Coomassie stained gel, 
(B) Far Western, (C) Zymogram. M: PageRuler
TM
 #SM0671 
 
 
This analysis revealed that the mutant strain had an identical CFE profile as compared to the 
wild-type, producing the ~45 kDa collagen adhesin (Figure. 5.3 B) as well as the protease of the 
same size as well as the ~37 kDa protease (Figure. 5.3 C). The OMP collagen adhesin profile 
(Figure. 5.4 B) was, however, different in the mutant strain as compared to the wild-type. The 
cbp- mutant did not produce either the 32 or the 34 kDa collagen adhesin band, indicating that 
the disruption of the cbp gene had resulted in the loss of the putative collagen adhesin. There was 
no change in the collagen zymography pattern in the OMP fraction of the cbp- mutant as 
compared to the wild-type strain (Figure. 5.4 C). 
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Interestingly, by insertionally interrupting the cbp gene, the 34 kDa adhesin band also 
disappeared. There are two possibilities for this phenomenon. The first is that the gene encoding 
the 34 kDa adhesin protein band might be located downstream of the cbp gene and that both are 
transcribed from the same promoter. In this scenario, by interrupting the transcription of cbp, the 
subsequent genes and their product are also not produced.   
 
This possibility was investigated by determining the genomic context of the B. fragilis YCH46 
Cbp is shown in Figure 5.5 A. The cbp gene and the genes surrounding it are conserved 
throughout the three published genomes of B. fragilis strains YCH46, NCTC 9343 and 638R 
(Figure. 5.5 B). It is, of course, important to keep in mind that the mutation of the cbp gene was 
done in the clinical isolate, B. fragilis GSH18, and that the conservation of the genes discussed 
would have to be confirmed in this strain.  
 
A 
 
 
 
B 
YCH46 ORF NCTC 9343 ORF 638R ORF GENE DES CRIPTION PREDICTED MW 
BF0660 BF0584 BF638R0631 Hypothetical protein 27 kDa 
BF0661 BF0585 BF638R0632 Putative tetrapyrrole (corrin/porphyrin) 
methylase 
25 kDa 
BF0662 BF0586 BF638R0633 Hypothetical protein  (cbp) 32 kDa 
BF0663 BF0587 BF638R0634 Putative haloacid dehalogenase-like 
hydrolase protein 
27 kDa 
BF0664 BF0588 BF638R0635 MarC family integral membrane protein 
(putative amino acid transporter) 
23.5 kDa 
 
Figure 5.5 Genomic context of the cbp. (A) Arrangement of genes in B. fragilis YCH46 (The cbp gene is 
highlighted in black); (B) ORF numbers and gene annotation in B. fragilis strains YCH46, NCTC9343 
and 638R. 
 
The cbp gene (BF0662 of strain YCH46) was found to be the middle gene in a cluster of five 
closely positioned genes which could form part of an operon. If this is the case then the 
interruption of the cbp gene could prevent the transcription of the two downstream genes. 
BF0660                        BF0661                                                BF0662                                                          BF0663                              BF0664 
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However, these genes are annotated as a putative haloacid dehalogenase- like hydrolase protein 
(BF0663 – YCH46) and a MarC family integral membrane protein (BF0664 – YCH46) with 
predicted protein sizes of 27 and 23.5 kDa respectively. Neither of these encodes a protein of the 
appropriate size, nor can their annotated function be linked to collagen adhesion, so the 
hypothesis that the cbp mutation causes a polar effect on another collagen binding protein seems 
unlikely. 
 
The second possibility is that the 34 kDa protein band is a post-translationally modified version 
of the Cbp protein. Post-translational modifications include processes such as phosphorylation 
and methylation. Using the NetPhosBac 1.0 server (Blom et al., 1999), which predicts serine and 
threonine phosphorylation sites in bacterial proteins, five potential serine phosphorylation sites 
(S 24, S 119, S128, S239 and S 277) were identified. 
 
Interestingly, the gene upstream of cbp is annotated as a putative tetrapyrrole methylase. 
According to the protein family database, Pfam (Finn et al., 2010), these methylases are involved 
in the methylation of substrates using S-adenosyl-L-methionine as a methyl source. Methylation 
is known to alter the function of target proteins and has been implicated in processes like signal 
transduction and transcriptional regulation (Grillo and Colombatto, 2005). If methylation of the 
B. fragilis Cbp is responsible for the adhesin band of increased molecular weight, the mutation of 
the cbp gene would account for the loss of the collagen adhesin doublet and not just the ~32 kDa 
band. Using the BPB-PPMS server (Shao et al., 2009), which performs in silico identification of 
protein methylation sites, two putative lysine methylation sites (K 102 and K 123) were 
identified.  
 
In Mycobacterium tuberculosis and Mycobacterium bovis a heparin-binding hemagglutinin 
adhesin (HBHA) and a laminin-binding protein (LBP), involved in extrapulmonary 
dissemination and cytoadherence respectively, were found to be methylated in vivo (Pethe et al., 
2002). This modification resulted in the apparent increase in the molecular weights of the 
adhesins. Methylation did not however appear to alter the affinity of HBHA for heparin-sulfate 
receptors but it was shown to protect HBHA and LBP from proteolytic degradation.  
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If a similar situation occurs in the case of the Cbp this could be determined in a similar manner 
to that used in Pethe et al. (2002), which is by mass spectrometry. Although determination of 
methylation by this method could have been performed as part of the LC-MS/MS analysis, done 
to determine the presense of Cbp (the BF0662 homologue) in the samples analysed, it was not 
known at the time that such an analysis would be of interest. Unfortunately due to the time and 
financial constraints associated in the sample preparation and analysis at the Yale Cancer Centre 
Mass Spectrometry Resource & W.M. Keck Foundation Biotechnology Resource Laboratory the 
United States of America, it was not possible in this thesis to accomplish this. The determination 
of methylation of the wild type Cbp and the mechanisms by which this modification occurs may 
be best analysed as part of a new study in which the methylation states of the wild type and 
recombinant proteins can be compared as was describe by Pethe et al.(2002).  
 
 
5.3.3  TWO-DIMENSIONAL ANALYSIS OF THE B. FRAGILIS GSH18 cbp- MUTANT 
 
Two-dimensional gel electrophoresis proved to be a powerful tool for the separation of the OMP 
fraction with the aim of identifying collagen adhesin protein spots (Chapters 3 and 4). Computer 
programs such as PDQuest software version 7.4.0 (Bio-Rad), used in this study, allow for 
detailed comparison of protein profiles under different sets of experimental conditions or in this 
case between a wild-type and mutant strain.  
 
The OMPs of B. fragilis GSH18 wild-type and B. fragilis GSH18 cbp- mutant strains were 
separated by 2D SDS-PAGE and examined by subsequent collagen Far Western analysis 
(Figure. 5.6).  It was observed that the mutant strain only produced the collagen adhesin spot of 
~54 kDa (Figure. 5.6 C – spot A) and none of the others seen in the wild-type (Figure. 5.6 C – 
spots B to E). PDQuest was used to analyse the wild-type and mutant gels. Spots B to E were 
those that were excised and analysed by LC MS/MS. Use of the spot matching tool revealed that 
protein spots C to E were still present in the cbp- mutant, but that spot B was missing from all 
mutant gels. The mass spectrometry results for the 2D SDS-PAGE gels (Table 4.3) showed that 
spot B has the greatest identity to BF0662 of B. fragilis YCH46. BF0662 was also detected in the 
case for spots C and D but these results had a much lower identity than that of spot B.  
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A                                                                                 A 
 
 
 
 
 
 
 
 
B                                                                                 B 
 
 
 
 
 
 
 
 
 
C                                                                                 C 
 
 
 
 
 
 
 
 
 
Figure 5.6. Comparison of collagen-binding proteins from the outer membrane of B. fragilis GSH18 wild-type and B. 
fragilis GSH18 cbp
-
 mutant by two-dimensional gel electrophoresis. OMPs were separated in the first dimension on 
precast IPG strips (pH 3–10) fo llowed by separation in the second dimension on 10% SDS-PAGE gels: (A) Coomassie 
stained gels;  (B) Magnified area of Coomassie stained gels shown in red box of (A); (C) Collagen Far Western of 
proteins from 2D-gels in the same magnified area indicated in the red box of (A);. M: PageRuler
TM
 #SM0671.  
 
 
The results of this work, therefore, confirm that Cbp is the collagen adhesin responsible for the 
collagen binding activity seen between about 32 and 35 kDa, and suggest that the collagen 
binding seen in spots C to E (Figure. 5.6 B – wild-type) was due to the presence of 
contaminating Cbp protein. 
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5.3.4 pET OVER-EXPRESSION OF THE CbpHis COLLAGEN ADHESIN  
 
To further prove that the cbp gene of B. fragilis GSH18 was, in fact, responsible for the 
production of a collagen adhesin of approximately 32 kDa, this gene was cloned into pET29b+ 
and expressed in E. coli. The fusion protein of Cbp with an S-Tag at the N-terminus and a C-
terminal hexahistadyl had a calculated molecular weight of approximately 35 kDa.  
 
 
A                                                                             B  
  M              1                2               3                4                   M            1                   2               3               4 
             
Figure 5.7 Expression of Cbp
His
. (A) Coomassie stained gel, (B) Anti-6-His Western. Lanes: (M) PageRuler
TM
 
#SM0671; (1) insoluble fraction of E. coli BL21(DE3) pET29b
+
; (2)  insoluble fract ion of  E. coli BL21(DE3) 
pETcbp; (3) soluble fraction of E. coli BL21(DE3) pET29b
+
; (4) soluble fraction of  E. coli BL21(DE3) pETcbp.      
 
A                                                                           B 
 M     1            2            3            4             5             M    1            2             3             4               5 
                 
Figure 5.8 Collagen far western analysis of Cbp
His
. (A) Coomassie stained gel, (B) Collagen Far Western. Lanes: 
(M) PageRuler
TM
 #SM0671; (1 ) insoluble fraction of E. coli BL21(DE3) pET29b
+
; (2)  insoluble fraction of E. coli 
BL21(DE3) pETcbp; (3) soluble fraction of E. coli BL21(DE3) pET29b
+
 ; (4) soluble fract ion of E. coli BL21(DE3) 
pETcbp; (5) 90µg OMP of B. fragilis GSH18 as a positive control. (*) indicate collagen adhesins in the E. coli 
protein background.       
 
After expression for 2 h at 30°C, the fusion protein, CbpHis was expressed in the recombinant     
E. coli BL21(DE3) pETcbp strain (Figure. 5.7 A, lanes 2 and 4). CbpHis was found 
predominantly in the insoluble fraction as can be seen by the presence of a distinct 35 kDa band 
(lane 2) not present in the control strain harboring only the parent vector (lane 1). Interestingly a 
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novel band of ~32 kDa is also seen in the pETcbp strain (lane 2). Confirmation of the presence 
of the CbpHis was done by western blot detection of the hexahistadyl using anti-6-His antibodies 
(Figure. 5.7 B). This showed that the two bands in E.coli BL21(DE3) pETcbp and possessed a 
hexahistadyl.  Although the reaction to the His-tagged proteins in the soluble fraction (lane 4) 
was weaker than that of the insoluble fraction (lane 2) it demonstrated that at least some of the 
CbpHis is soluble during the expression protocol used which will assist in the purification of the 
recombinant protein for use in future studies. The E.coli BL21(DE3) pET29b+ negative control 
strain only displayed a faint band at ~32 kDa in the soluble fraction (lane 3, Figure. 5.7 B) but 
this was attributed to non-specific binding of the anti-6-His antibodies to E. coli proteins. 
 
To analyse for the ability of the recombinant CbpHis to bind to collagen, SDS-PAGE and Far 
Western analysis was performed (Figure. 5.8) using B. fragilis GSH18 OMP as a positive control 
(lane 5). Both the ~35 and ~32 kDa bands were able to bind collagen as compared to the positive 
control (lane 5). It should also be noted that other collagen binding adhesins were detected in the 
E. coli background in all fractions, as seen at about 44 kDa And 54 kDa, indicated with asterisks 
(*) (Figure. 5.8 B), but not at the ~32 kDa position where the non-specific binding of anti-6-His 
antibodies had been observed (lane 3, Figure. 5.7 B). There is very little reported information on 
collagen type I adhesins of E. coli that could be used to interpret this data.  An EhaB 
autotransporter protein of E. coli O157:H7 has been shown to bind to laminin and collagen Type 
I, but this has a size of 107 kDa (Wells et al., 2009) and is, therefore, clearly not among the 
proteins visualized in Figure 5.8.  
 
The 32 kDa band, having a smaller molecular weight than the one predicted for the CbpHis is, 
therefore, not modified in the same manner as the wild-type Cbp in B. fragilis. This was also the 
case with the recombinant heparin-binding hemagglutinin adhesin (HBHA) of M. tuberculosis 
and M. bovis, mentioned in section 5.3.2., which was not methylated when produced in E. coli 
(Pethe et al., 2002). This smaller sized band is likely to be the CbpHis without the S-Tag which is 
of about 2.8 kDa. Proteolytic cleavage of this tag can occur at a thrombin site found between the 
S-tag and the cloned gene. For future work requiring pure CbpHis found in one conformation, 
protease inhibitors will have to be included in the protein preparation to avoid removal of the S-
Tag or the S-Tag will have to be removed completely in a controlled fashion.  
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5.4 CONCLUSION 
 
In this chapter, the aim was to determine whether the putative collagen binding protein gene, 
cbp, was responsible for the production the collagen adhesin of approximately 32 kDa. This was 
successfully achieved by using two methods to functionally characterize this gene. The first was 
insertional inactivation of the cbp gene to prevent the production of the Cbp in B. fragilis 
GSH18. The mutation was confirmed by PCR with a combination of primers internal to the 
suicide vector, pGREM and primers for the full length gene, followed by sequencing of the PCR 
products. 
 
The wild-type and mutant strains were compared by one dimensional gel electrophoresis in 
combination with collagen zymography and far western analysis, to reveal the loss of the ~32 
and ~34 kDa adhesin bands, but no loss of the ~45 kDa adhesin or the ~45 kDa and ~37 kDa 
collagen protease bands. Two-dimensional PAGE of the OMPs of the two strains also revealed 
the loss of collagen binding activity at the 32 – 35 kDa area, but again retained the collagen 
binding spot seen at about 54 kDa. In the second approach the cbp gene was cloned and 
expressed in E. coli and the recombinant CbpHis was shown to bind collagen as well.  
 
This is, to our knowledge, the first report of the identification of a collagen binding protein in    
B. fragilis, which is now available for further characterisation. Future work will include 
resolving any possible mechanisms of post-translational modification of the protein, which could 
result in the production of an adhesin with a greater apparent molecular mass and similarly if 
these modifications have any influence on the affinity of Cbp for collagen.  It would also be of 
interest to determine the involvement, if any, of the putative methylase gene found directly 
upstream of cbp, and whether this alleged modification on the Cbp has any effect on the 
protein‟s function.  
 
The experimental approach undertaken in this dissertation has allowed for the assignment of 
function to the cbp gene, annotated as a hypothetical protein encoded by the ORF BF0662 in     
B. fragilis YCH46. This gene sequence had no detectable conserved domains and without the 
functional identification used here, its role in B. fragilis would not have been easily elucidated.   
110 
 
 
111 
 
CHAPTER 6 
 
General conclusions and future research 
 
The increasing incidence of antibiotic resistance in the important human opportunistic pathogen, 
B. fragilis, has prompted the search for new therapeutic targets such as virulence factors 
(Barczak and Hung, 2009). In this dissertation, the emphasis has been on a particular subset of 
putative virulence factors in B. fragilis, namely adhesins and proteases that target the main 
component of the human extracellular matrix, collagen. 
 
At the beginning of this study, little was known about the relationship of B. fragilis to this 
substrate. Previous studies had not been able to show any evidence of its ability to degrade 
collagen (Gibson and Macfarlane, 1988b; Patrick, 2002), although, a few instances of activity 
against collagen- like substrates, such as Azocoll and gelatin, had been reported (Chen et al., 
1995; Moncrief et al., 1998). The ability of various B. fragilis strains to adhere to collagen type I 
had, however, been established (Szoke et al., 1996; Szoke et al., 1997). It is important to note 
that, even though collagen type I is the most abundant type found in the human body, it is not the 
collagen type that this bacterium is most likely to encounter. The basal lamina, which underlies 
endothelial and epithelial cells, in fact contains the non-fibrillar, or net-work forming, type IV 
collagen. In this study, however, we chose to begin investigating the relationship with this ECM 
component using the only collagen type that B. fragilis had been, thus far, confirmed to interact 
with, namely collagen type I.  
 
With the ability of B. fragilis to bind this substrate already established, the first step in this study 
was to assess whether or not it could degrade it. Using zymography, it was determined tha t it did, 
in fact, hydrolyse collagen type I and that a distinct protease band of about 45 kDa and several 
other zones of clearing were present. This prominent collagenolytic band was observed in the 
extracellular fraction as well as in the CFEs and in the OMP fraction. Initial attempts to use 
bioinformatic searches of the annotated genomes of B. fragilis to look for candidate collagenase 
genes proved to be a somewhat narrow approach. The best candidate gene from in silico 
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analyses, annotated as a prtC-like protease, was shown not to be responsible for the degradation 
of collagen seen here. 
 
This candidate gene was, however, found in a putative gene cluster with very high similarity to 
its P. gingivalis counterpart. Although interruption of this gene showed that it was not 
responsible for the production of this particular collagen type I collagenase, it may have 
alternative substrates or require specific gene induction conditions, which were not investigated 
here. Further studies of this gene cluster would be, therefore, of great interest. 
 
Having discovered the presence of specific collagen degrading enzymes, the next objective was 
to investigate the mechanisms of collagen type I adhesion. The first step was to determine if the 
previously reported differences in the ability of B. fragilis strains to bind collagen were also seen 
within the subset of clinical strains available for this study. The initial discovery of the collagen 
proteases had been performed using the B. fragilis 638R strain. Although various genetic tools, 
such as insertional mutagenesis, had been well documented for use with this strain, it was 
important to make sure that it was in fact the best candidate for the study. Using particle 
agglutination assays, both as a measure of affinity for collagen and as an indicator of virulence, it 
was seen that B. fragilis 638R was in fact not the best candidate strain, and so studies were 
continued using the more adherent clinical isolate, B. fragilis GSH 18. 
 
Using this strain, the presence of four collagen adhesin proteins was established. A ~45 kDa 
adhesin was observed in the CFE and a ~54 kDa collagen binding protein as well as an adhesin 
doublet, containing ~32 and a ~34 kDa bands, were found in the OMP fraction. The presence of 
an adhesin of a similar size to the predominant collagenase band (45 kDa) suggested this could 
be a collagenase with a collagen binding domain and, therefore, it was hoped that collagen 
affinity purification would also allow for the isolation of the respective collagenase.  
 
Collagen affinity purified and 2D PAGE separated putative collagen adhesin proteins were 
analysed by mass spectrometry and the predicted protein sequences of the published genomes 
were used for comparison of the resulting protein sequence information. The LC MS/MS method 
used allows for analysis of mixed protein samples which meant that good quality results were 
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obtained after relatively limited purification procedures. Unfortunately, the wealth of information 
that resulted from this analysis did not allow for easy determination of the identity of all the 
proteases and adhesins of interest. No distinct putative collagenase genes were identified. In fact 
very few protease genes were seen at all. A similar experience was reported by Houston et al. 
this year (2010) where their mass spectrometry analysis of B. fragilis extracellular proteins 
between 35 and 60 kDa in size yielded no putative protease gene candidates.  
 
The identity of the genes encoding the collagenase activity bands observed in this study was 
unfortunately not established. Fresh approaches to this task will have to be looked at in future 
studies. In spite of the difficulties associated with expressing B. fragilis promoters in E. coli, the 
production of a gene bank could be a viable alternative, since a number of B. fragilis genes have 
been identified in this way, an example being the glutamine synthetase gene glnA (Southern et 
al., 1986). Alternatively, every putative protease gene identitfied in silico could be expressed in      
E. coli by cloning the genes into vectors, such as pET, in which expression is mediated by E.coli 
compatible promoters, such as the lacZ promoter. More robust screening methods, including the 
use of gelatin or casein agar, could be used to select for collagenase positive clones and, 
similarly, for collagenase deficient transposon mutants of B. fragilis. The recent publication 
mentioned above (Houston et al., 2010) already hints at the substrate promiscuity of the ~45 kDa 
collagenase observed in this study. In it two fibrinogen degrading protease bands, of ~45 and 50 
kDa were observed using fibrinogen zymography. It would be very interesting to see if the same 
enzyme is responsible for both the proteolytic activities. Failing this, however, the use of 
extensive protein purification methods will have to be employed.   
 
The LC MS/MS analysis also didn‟t identify any genes annotated as putative collagen 
MSCRAMMs. The only proteins identified which have been at all linked to the adhesion of         
B. fragilis to human cells or ECM components were the major outer membrane protein, OmpA 
(Pumbwe et al., 2007), and the plasminogen and laminin binding protein Bfp60 (Ferreira et al., 
2009; Sijbrandi et al., 2008). Although these proteins did not appear to be ideal candidates for 
the particular adhesins of interest in this study, it may still be of interest to follow up on their 
relationship with collagen. Deletions mutants of the ompA1 to 7 genes have already been created 
and tested for alterations in their ability to deal with several stress conditions, such as oxygen 
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exposure and osmotic stress (Wexler et al., 2009). These could similarly be tested for alterations 
in their human cell binding ability and for the specific loss of any of the collagen adhesins. No 
reports of bfp60 have been published although the gene has been successfully expresses in E. coli 
(Ferreira et al., 2009; Sijbrandi et al., 2008). Interestingly the recent study by Houston et al. 
(2010) discussed above, reports on the identification of a fibrinogen binding protein (BF-FBP) of 
54 kDa, which is the same size as one of the collagen adhesins seen in this study. However, BF-
FBP is encoded by the BF1705 ORF of B. fragilis NCTC 9343 (BF1698 of YCH46), which was 
not identified in the LC MS/MS results described here. It remains of interest to follow up on 
whether or not this protein has any affinity for collagen type I as well.  
 
A large number of proteins, identified as hypothetical proteins of unknown function were seen in 
the mass spectrometry results in this study. This was a very interesting observation as it indicated 
that a significant number of proteins being expressed by B. fragilis have little to no genetic and 
protein sequence similarity to known functional proteins. This confirms that the difficulty 
experienced in finding putative protease gene candidates at the beginning of the study is not 
surprising.  
 
One such hypothetical protein encoding gene proved to be responsible for the production of not 
one but two of the collagen adhesin bands observed by collagen Far Western ana lysis. The 
homologue of the BF0662 ORF of B. fragilis YCH46, referred to in this study as cbp, was 
mutated in the clinical strain B. fragilis GSH18, demonstrating the loss of the collagen adhesin 
doublet of ~32 and a ~34 kDa. The cbp gene expression in E. coli confirmed the collagen 
binding phenotype of the protein expressed by the gene. Possible reasons for the production of 
the adhesin doublet by the same protein coding gene have been discussed. The possibility of 
post-translational modifications of the Cbp protein and the involvement of the putative methylase 
gene, found upstream of cbp in the three published B. fragilis genomes, is to be the one of the 
focuses of the follow up study of this collagen adhesin. The other focus will be on establishing 
the contribution of this gene to the ability of B. fragilis to adhere to collagen,  and to human cells 
as a possible indicator of its participation in the virulence potential of B. fragilis. The latter can 
now easily be done by comparing the wild-type B. fragilis GSH 18 to the cbp- mutant of the same 
strain, produced in this study, using methods previously described for B. fragilis in the context of 
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the interaction with other ECM components like laminin (Ferreira et al., 2002; Ferreira et al., 
2006).  
 
The work presented in this dissertation, therefore, describes for the first time the production of 
proteases and adhesins with the ability to, respectively, bind to and degrade fibrillar collagen 
(type I). Although the identification of the collagenase proteins was not successful, the 
development of the collagen zymography technique for use in the context of B. fragilis is an 
important development in the study of these proteases. Similarly, the use of the collagen type I 
Far Western analysis with B. fragilis has allowed for the detection of specific adhesins to this 
substrate. Although Far Western analysis of 2D SDS-PAGE separation of proteins has been 
previously described, this is, to our knowledge, the first report of the technique being used with 
collagen Far Western analysis.   
 
This study, especially with the identification of the first collagen binding protein of B. fragilis, 
Cbp, has opened the doors to the investigation of the relationship of this important human 
opportunistic pathogen and the main component of the human ECM, collagen. The identification 
of molecules which mediate the interaction of B. fragilis to any ECM component may eventually 
lead to the development of inhibitors of these adhesive and proteolytic properties to be used as 
potential therapeutic methods.  
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